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Abstract 
 
Understanding antiviral processes in infected organisms is of great importance when 
designing tools targeted at alleviating the burden viruses have on our health and society. Our 
understanding of innate immunity has greatly expanded in the last 10 years, and some of the 
biggest advances came from studying pathogen protection in the model organism Drosophila 
melanogaster. Several antiviral pathways have been found to be involved in antiviral 
protection in Drosophila however the molecular mechanisms behind antiviral protection have 
been largely unexplored and poorly characterized. Host-virus interaction studies in 
Drosophila often involve the use of two model viruses, Drosophila C virus (DCV) and Flock 
House virus (FHV) that belong to the Dicistroviridae and Nodaviridae family of viruses 
respectively. 
  
 The majority of virus infection assays in Drosophila utilize injection due to the ease 
of manipulation, and due to a lack of routine protocols to investigate natural routes of 
infection. Injecting viruses may bypass the natural protection mechanisms and can result in 
different outcome of infection compared to oral infections. Understanding host-virus 
interactions following a natural route of infection would facilitate understanding antiviral 
protection mechanisms and viral dynamics in natural populations. In the 2nd chapter of this 
thesis I establish a method of orally infecting Drosophila larvae with DCV to address the 
effects of a natural route of infection on antiviral processes in Drosophila. To confirm 
productive infection, I designed a single-stranded RT-qPCR assay. Using this assay I show 
that larvae that survive beyond 24 h post-contamination are not persistently infected.  
 
Establishing a method of orally infecting Drosophila flies allowed the subsequent studies 
to focus on antiviral mechanisms following a natural route of virus infection. While host-
derived defence mechanisms, such as immunity, are important for mediating antiviral 
protection, extrinsic protection mechanisms such those provided by the endosymbiotic 
bacteria Wolbachia pipientis can also confer antiviral protection in Drosophila. Wolbachia is 
a maternally transmitted intracellular alpha-proteobacteria found in a large number of 
arthropods and nematodes which can mediate antiviral protection against a range of viruses 
including DCV, FHV and Cricket paralysis virus. The 3rd chapter focuses on understanding 
the antiviral effects of Wolbachia on viral tolerance following oral infection of Drosophila 
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larvae and adults. The results showed that in adults, Wolbachia strains that confer viral 
tolerance following systemic DCV infection do so also following oral DCV infection. 
Interestingly, Wolbachia-mediated protection was life-stage dependent as oral feeding of L1 
stage larvae resulted in a loss of Wolbachia-mediated protection in 3 out of 4 Drosophila-
Wolbachia associations shown to be protective at the adult stages. Loss of protection was 
associated with lower Wolbachia densities at larval compared to adult stages in the same 
three Drosophila-Wolbachia associations. These results will aid in understanding the effects 
of Wolbachia on viral dynamics in natural populations and will contribute to our 
understanding of life-stage susceptibility in Drosophila.  
 
In the 4th chapter the role of apoptosis in mediating antiviral protection was studied 
following both viral injections (systemic infection) and oral infections using FHV as a model. 
Using altered gene expression of key genes involved in apoptosis I investigated the 
importance of apoptosis on antiviral protection. Knocking-out a pro-apoptotic transcription 
factor dP53 in adult flies lead to an increase in viral titers following a systemic FHV infection 
and resulted in earlier mortality of infected individuals compared to wild type flies. Contrary 
to systemic infection, oral FHV infection of the same fly line showed no effect on viral 
accumulation but led to earlier mortality of infected individuals. Over-expressing a pro-
apoptotic gene reaper lead to a reduction in FHV viral titers following both systemic and oral 
infections, however while a reduction in viral titers lead to a delay in virus-induced mortality 
in systemically infected flies, no differences in mortality was observed between wild type and 
mutant flies following oral infection. Oral infection with FHV caused 30 % mortality in both 
wild type and P53 and reaper over-expressing flies. The similarities in the number of flies 
succumbing to oral infection indicates that apoptosis does not impact the outcome of initial 
challenge, but that it likely functions in protection following primary infection. Depending on 
whether apoptosis was suppressed or enhanced lead to differences in the effects of apoptosis 
on resistance (ability of the host to control virus accumulation) and tolerance (ability of the 
host to endure infection), which lead to the idea that viral tissue tropism could be responsible 
for the differences in resistance versus tolerance. 
 
 Taken together the results enhance our understanding of antiviral mechanisms in 
Drosophila and show that both the route of infection and life-stage can have important 
impacts on antiviral mechanisms. The methods used to orally infect flies with both DCV and 
FHV will be valuable in facilitating research focused on Drosophila-pathogen interactions 
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following the oral route of infection and will hopefully encourage more research to focus on 
understanding the effects of oral infections on host-virus interactions. 
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Viruses that infect arthropod species can carry a heavy burden on society. Insects like mosquitoes 
can transmit a diverse range of human viruses such as dengue, West Nile and chikungunya viruses. 
The cost to the economy for dengue virus alone is up to $1.8 billion US per year, and poses a 
significant risk to human health (1). While viruses can be detrimental to human health and the 
economy, they can also be used to our advantage. Viruses have started gaining ever greater 
interested for their use as insecticides to control pests affecting several economically important 
crops (2). Whether our aim is to restrict or enhance viral spread, understanding viral dynamics is 
essential.   
 
Understanding viral dynamics requires knowledge of the molecular pathways involved in 
regulating host-virus interactions. Genetic techniques used to dissect the molecular pathways 
involved in protection against virus invasion can be challenging to apply. Drosophila melanogaster 
has emerged as a model organism to study host-virus interactions in arthropods for several reasons. 
As one of the original genetic models, Drosophila has well established tools and procedures, and is 
easy and inexpensive to culture in the lab. Genetic manipulation in Drosophila is well characterized 
and easily achieved. An extensive selection of Drosophila flies are available that possess null 
mutations in a range of genes, which can be used to study gene function and molecular pathways. 
As well as null mutants, a large collection of flies exists, where genes can be knocked-down or 
over-expressed in specific tissues at different developmental stages. Furthermore, Drosophila is a 
good model organism to study innate immune system regulation, due to the conservation of innate 
immunity throughout evolution. 
  
Pathogens often infect arthropod populations, making it essential for the host to possess 
protection mechanisms to fight infection. Defence against pathogen entry and invasion have ancient 
origins, as genetic studies have found that pathogen defence mechanisms existed in the ancestors of 
plants and animals before they diverged (3). Due to the importance of the defence system, immunity 
has remained very well conserved between organisms through evolution. In Drosophila, the 
molecular mechanisms required for protection against bacterial and fungal infections have been 
well characterized, while antiviral molecular mechanisms remain poorly characterized (4). A wide 
range of viruses from diverse families have been used to study Drosophila-virus interactions, some 
of which infect natural Drosophila populations, while others are artificially delivered (Table 1). 
Availability of a variety of viruses that can successfully infect Drosophila allows for a comparative 
analysis to identify both virus-specific and broad antiviral responses in Drosophila. Expanding our 
knowledge of antiviral mechanisms in Drosophila will allow us to determine the role they play in 
protection, and could provide us with the opportunity to understand and control viral dispersion.  
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Table 1: Commonly studied viruses in Drosophila 
  
Name Abbreviation Family Natural pathogen Genome 
Sigma virus SIGMAV Rhabdoviridae YES ss -RNA 
Drosophila C virus DCV Dicistroviridae YES ss +RNA 
Drosophila X virus DXV Birnaviridae YES ds RNA 
Drosophila F virus DFV Reoviridae YES ds RNA 
Gypsy virus Gypsy Errantiviridae YES ss +RNA 
Nora virus Nora Unclassified YES ss + RNA 
Cricket paralysis virus CrPV Dicistroviridae YES ss +RNA 
Flock House virus FHV Nodaviridae NO ss +RNA 
Invertebrate iridescent virus IIV-6 Iridoviridae NO DNA 
Sindbis virus SINV Togaviridae NO ss +RNA 
Culex nigripalpus virus CuniNPV Baculoviridae NO DNA 
Vesicular stomatitis virus VSV Rhabdoviridae NO ss -RNA 
 
 
Host – virus interaction  
Drosophila C virus (DCV) 
DCV is the most well studied Drosophila virus, and has been used extensively to study 
Drosophila’s antiviral immune responses (5). DCV was first isolated from a D. melanogaster strain 
Charolles in 1972 (6), and has since been shown to infect numerous Drosophila species in natural 
populations (7). Different DCV isolates exist depending on their geographical location (8). The first 
DCV isolate was isolated from the French Charolles flies, and was named DCVC, while the strain 
used throughout all the experiments in this thesis is the Australian isolate DCVEB (8). DCV is a 
member of the Dicistroviridae family and is a single stranded + sense RNA virus, with a genome 
comprising 9264 nucleotides (9). The genome contains two open reading frames (ORF); ORF1 
encodes a helicase, protease and a RNA-dependent RNA polymerase, while ORF2 encodes a 100 
kDA polyprotein, which is processed to form the capsid proteins (9). During infection, the virus 
replicates its genome by synthesizing the – strand RNA, which is then used to make more + strand 
RNA. The – strand RNA is not encapsidated in virus particles and can be detected only in cells with 
actively replicating virus. The icosahedral viral capsid is composed of 4 major proteins VP1 (33 
kDa), VP2 (29 kDa), VP3 (29 kDa) and VP4 (8.5 kDA), however it is also possible to detect the 
protein VP0 (37 kDa) which is the precursor of VP3 and VP4 (10).  
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DCV infection  
Studies on antiviral responses in Drosophila often use DCV as a model virus due to its high 
pathogenicity. Following DCV injection into the heamocoel, the virus becomes internalized by 
clathrin-mediated endocytosis (11). Once inside the cells, DCV remodels the Golgi apparatus and 
forms a vesicle on which viral replication occurs (12, 13). Vesicle formation requires the coat 
protein complex I (COPI) and fatty acid biosynthesis, both of which are essential for DCV 
replication (13). Once DCV becomes established inside the cells, it kills its host within 4-6 days 
post injection (dpi) (6, 14). While DCV infection is extremely pathogenic following viral injection, 
infection of adult flies through feeding on contaminated media is much less pathogenic and causes 
~15 % mortality within 4-8 days post ingestion (15).  
 
DCV is often detected in natural Drosophila populations (7), however the mechanism 
through which infection occurs is not fully understood. Studies on DCV infection have primarily 
been performed in Drosophila cell cultures and through intra-thoracic injections of adult flies. 
Neither of these infection mechanisms are representative of the way DCV infection occurs in 
nature. In natural Drosophila populations DCV infection is thought to occur through ingestion of 
virus-contaminated food (16). Experiments performed in the mid 80’s by Thomas-Orillard and 
colleagues claim to have achieved natural DCV infection by feeding DCV infected fly homogenates 
to first instar larvae (17). To confirm that larvae were successfully infected, the flies suspected of 
being infected with DCV were ground in a buffered solution and injected into DCV free flies to 
score daily mortality. When DCV infected fly homogenates were injected into DCV free flies, 93 % 
of flies died within 3-4 dpi, which led the authors to conclude that flies feeding on DCV 
contaminated media become infected with DCV (17). While the above-mentioned method is 
suitable for detecting viral contamination, it cannot distinguish between viral contamination and 
infection. When larvae feed on DCV contaminated media, the virus settles on the cuticle and/or on 
the surface of the digestive tract, without necessarily entering the internal organs and causing an 
infection. Furthermore, because the flies were pooled before the homogenates were injected into 
DCV free flies, it is not possible to analyse the percentage of flies that became infected after feeding 
on contaminated media.  
 
Other studies focused on natural DCV infection found that DCV can form both mutualistic 
and parasitic relationships with its host, depending on the environmental conditions (18). When 
flies were exposed to DCV through the rearing media, it was reported that the virus can provide 
several advantages to the fly, such as increased fertility, increased adult weight and a decreased 
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developmental time (17). Although the interpretation that DCV can form mutualistic relationships 
with Drosophila were consistent with the results, an alternative interpretation could not be 
discounted. Because DCV increases egg to adult mortality (16), it is reasonable to postulate that 
larvae with the lowest fitness will be the ones to succumb to DCV infection before adult emergence. 
Elimination of the weakest individuals before adult emergence would make the remaining adult 
population appear fitter, and therefore more likely to show an increase in adult weight, fertility and 
a decrease in developmental time, therefore skewing the results and leading to the conclusion that 
DCV infection increases the fitness of the individual. Due to experimental techniques used in the 
abovementioned experiments, it is hard to determine whether DCV can indeed form mutualistic 
relationships with Drosophila. 
 
Studying the natural route of infection is interesting for several reasons. DCV pathogenicity 
is much lower following ingestion of the virus compared to injection (15), suggesting that natural 
barriers to infection exist that are bypassed through injection. Evidence suggests that DCV tissue 
tropism can be affected by the route of DCV infection. When DCV is injected intra-thoracically, all 
infected flies show DCV localization in the crop, midgut, hindgut, fat body, testis and trachea, while 
oral DCV infection in most cases shows DCV to be confined only to some of these tissues (15). The 
route of virus infection does not only affect viral tissue tropism, but can also affect the ability of the 
host to mount an immune response against pathogen invasion (15). A recent study showed that the 
Toll immune pathway in Drosophila is responsible for limiting replication of both DCV and Flock 
House virus (FHV) when the viruses are ingested, however it does not limit viral replication 
following viral injection, pointing to the importance of the route of viral entry on viral dynamics 
(15).  
 
The study of viral dynamics following the natural route of virus infection has been impeded 
by the lack of robust tools available to induce DCV infection through the oral route of infection, and 
the ability to distinguish between virus infection and contamination. Designing methods capable of 
inducing oral DCV infection in both larvae and adult, and designing tools able to detect virus 
infection would be essential to advance our knowledge of the host’s defence mechanisms in natural 
insect populations. Using the oral route of virus infection would furthermore allow us to study viral 
dynamics and how it relates to natural insect populations, and would allow us to study Drosophila’s 
natural protective barriers involved in limiting viral entry and replication.  
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Flock House virus  
Antiviral responses in Drosophila may vary depending on the virus infecting the organism. Flock 
House virus (FHV) has often been used to study immune responses in Drosophila and it belongs to 
the Nodaviridae family of viruses (19). FHV is a non-enveloped, icosahedral single stranded + 
sense RNA virus, and can replicate in insects, yeast, plants and mammalian cells (19-23). The 
genome is divided into two RNAs, RNA1 (3.1 kb) and RNA2 (1.4 kb) (19, 24, 25). RNA1 encodes 
for protein A, which is an RNA-dependent RNA polymerase, and is required for transcription of 
both genomic strands and the subgenomic RNA3 (25-27). The subgenomic region contains two 
open reading frames, which encode the proteins B1 and B2, while the genomic RNA2 encodes the 
precursor of the coat protein (28). The function of the protein B1 is unknown, however it is known 
that the protein B2 suppresses the cleavage of double-stranded RNA, responsible for the inhibition 
of small interfering RNA (siRNA) formation, therefore suppressing the RNA silencing pathway 
(29-31).  
  
FHV is not a natural Drosophila pathogen, however it can replicate inside Drosophila cells. 
Injecting FHV into the haemocoel of adult Drosophila causes death of the host within 7-8 dpi (14, 
32), while oral FHV infection is much less pathogenic, and causes 10-15 % mortality within 13 
days of ingestion (15).  
 
Antiviral defence mechanisms in Drosophila 
Viruses are obligate intracellular parasites and require the host’s cellular machinery for replication. 
Conversely, the host tries to prevent the establishment of viruses within the cellular compartments 
by mounting a defence response. The constant struggle between viruses and hosts has led to the 
evolution of several well-conserved antiviral pathways, of which we are only beginning to 
understand the molecular mechanisms. While humans have evolved both the adaptive and innate 
immune system, Drosophila lacks the adaptive immune system, and uses the innate immune system 
as the primary tool to control viral infections (33). Drosophila’s innate immune system uses the 
pattern recognition receptors (PRRs) to recognize pathogen-specific pathogen associated molecular 
patterns (PAMPs) to mount an immune response (reviewed in 34). Several distinct viral defence 
mechanisms have evolved in Drosophila, providing protection against a diverse range of viruses 
(Figure 1). What follows is an overview of the known antiviral defence mechanisms in Drosophila, 
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in order to summarise and discuss the advances made in this field, and identify areas where further 
research is required.  
 
Figure 1. Antiviral defence pathways in Drosophila. The figure summarizes the immune 
pathways involved in antiviral protection in Drosophila. Shown are the sensing molecules for each 
pathway. For the JAK-STAT, Toll, Imd and Autophagy pathways, the sensing molecules are 
cellular receptors. For the RNAi pathway the sensing molecule is Dicer-2 found in the intracellular 
department, while the sensing molecule for virus-induced apoptosis has not yet been described, 
therefore is marked with a question mark. For each pathway the viruses against which it confers 
antiviral protection are shown. 
 
RNA interference pathway (RNAi) 
The RNAi pathway is one of most well characterized antiviral pathways in Drosophila. The 
effectors of the RNAi pathway are small non-coding RNAs, which function in chromosome 
segregation, chromatin structure, RNA processing and stability, transcription, and immunity (35). 
The three major pathways are: micro RNA (miRNA), piwi-interacting RNA (piRNA) and small 
interfering RNA (siRNA), with the latter being predominantly responsible for protection against 
viruses (34). Recognition of pathogens through the siRNA pathway occurs through recognition of 
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double-stranded viral RNA intermediates by Dicer-2 (Figure 1) (33). Dicer-2 processes dsRNAs 
into small siRNAs fragments 21 nucleotides long (36, 37). The siRNAs are subsequently loaded 
onto the RNA induced silencing complex (RISC). The siRNAs guide the RISC complex to the 
complementary messenger or virus RNA where Argonaute-2, the catalytic component of RISC, 
cleaves the target viral RNA. Cleavage of viral RNA limits viral replication and can prevent a 
systemic infection. Drosophila in which Dicer-2 or Argonaute-2 genes have been deleted show 
hypersensitivity to DCV, FHV and Cricket paralysis virus (CrPV) infections (38-40). Co-evolution 
between Drosophila and viruses has led the viruses such as DCV, FHV, CrPV and the invertebrate 
iridescent virus 6 (IIV-6) to evade the RNAi system by expressing RNAi suppressors, which target 
Dicer-2 or other components of the machinery to avoid processing (29, 31, 38, 41, 42).  
Janus kinase signal transducer and activator of transcription pathway (JAK-STAT)  
The JAK-STAT pathway has several roles and is essential in embryonic segmentation, formation of 
the eye, cell differentiation, cell movement and immunity (43, 44). In Drosophila, the JAK-STAT 
pathway is involved in protection against both viruses and bacteria (44). Recognition of viral 
particles leads to dimerization of the Jak tyrosine kinase Hopscotch and a single Stat transcription 
factor (Stat92E).  Dimerization of Stat92E causes nuclear translocation, where transcriptional 
activation of genes containing Stat-binding sites occurs (45, 46). Genetic studies have shown that 
mutants in the Hopscotch receptor show increased susceptibility to infection with DCV, FHV and 
CrPV viruses, suggesting the importance of the JAK-STAT pathway in the antiviral response in 
Drosophila (4). While clear evidence exists for the involvement of the JAK-STAT pathway in 
immunity, it remains to be determined how transcriptional activation of genes containing Stat-
binding sites leads to inhibition of viral replication. 
Immune deficiency pathway (Imd) 
The Imd pathway forms part of the innate immune system in Drosophila, and has been implicated 
mainly in protection against fungi and bacteria (47). Following bacterial infection, the pathogens 
are recognized through the pathogen-associated molecular patterns (PAMPS) present on the surface 
of bacteria. The activation of the Imd pathway requires the activation of the transcription factor 
Relish, which once activated translocates into the nucleus and facilitates the activation of 
antimicrobial peptides (AMPs) (48). AMPs have a large spectrum of antimicrobial activity and can 
inhibit replication of fungi, bacteria and viruses through a range of mechanisms (49). While the 
molecular mechanisms controlling the host’s antibacterial response are well characterized, very 
 9 
little is known about how activation of the Imd pathway leads to inhibition of viral replication. In 
genetic studies where the transcription factor Relish has been deleted, a reduction in Sindbis virus 
(SINV) titer was observed (50). Furthermore, null mutants in several genes involved in the Imd 
pathway (peptidoglycan recognition proteins, transforming growth factor-activated kinase 1, 
immune response deficient 5, Kenny and Relish) show increased susceptibility to CrPV and SINV 
infection, suggesting the involvement of the pathway in antiviral protection (51).  
Whether the Imd pathway suppresses viral replication through the activation of AMPs or 
whether an alternative mechanism exists is not yet clear. Evidence for the existence of an alternative 
mechanism comes from studies focusing on CrPV infection, where the Imd pathway was shown to 
confer antiviral protection in an AMP-independent manner (51). No studies to date have determined 
the involvement of the Imd pathway in protection against DCV infection, however transcriptional 
profiling of DCV infected Drosophila cells has shown up-regulation of genes involved in the Imd 
pathway, and induction of antimicrobial peptides one hour post-incubation (52).  
Toll pathway 
Compared to other immune pathways, relatively little is known about the involvement of the Toll 
pathway in response to viral infection. Similarly to the Imd pathway, the Toll pathway is involved 
in protection against fungi, bacteria and viruses (53-55). The Toll pathway recognizes PAMPS 
through the PRR receptors referred to as Toll-like receptors (reviewed in 56). Following bacterial 
and fungal infection, activation of the Toll pathway leads to the production of antimicrobial 
peptides responsible for limiting fungal and bacterial replication (57). Loss-of-function mutants in 
two Toll pathway genes (Dorsal-related immunity factor and Dorsal) are significantly more 
sensitive to Drosophila X virus (DXV) infection, suggesting the involvement of the Toll pathway in 
antiviral protection (55). Furthermore, DXV infection induces production of several AMPs 
(Drosomycin, Diptericin, Defensin, Attacin, Cecropin, Drosocin and Metchnikowin) however 
constitutive expression of these AMPs in adult flies does not alter DXV titres, suggesting an 
alternative mechanism of viral inhibition (55). Furthermore, deletion of several key Toll pathway 
genes (Spatzle, Toll, Pelle and Dorsal) leads to increased sensitivity to oral infections with FHV, 
CrPV and Nora virus, but shows no such effect upon viral injection, suggesting that the 
involvement of the Toll pathway in antiviral protection is dependent on the route of infection (15). 
The exact molecular mechanism involved in Toll-mediated antiviral protection is still unclear, and 
further research is required to elucidate the molecular mechanisms.  
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Autophagy 
Nine known Toll-like receptors exist in Drosophila, and not all of them activate the Toll pathway, 
but some are involved in activating a different immune pathway known as autophagy. Autophagy in 
Drosophila plays an important role in development and is involved in hematopoesis and cell death 
during morphogenesis at the larval developmental stages (58, 59), Furthermore, autophagy forms an 
essential part of the innate immune system, and acts as a protective mechanism against viral and 
bacterial infections (60). Autophagy is a catabolic process involved in degradation of cellular 
components. The process begins by the formation of the pre-autophagic structure that acts as a 
nucleation point for the formation of a double membrane called the autophagosome, which contains 
the cellular material destined for degradation (61). Following the engulfment of the cellular material 
by the double membrane, the autophagosome fuses with lysosomes where degradation of cellular 
materials occurs, and culminates in the death and removal of the cell (61). In Drosophila, the Toll-
like receptor Toll-7 is required for the recognition and induction of autophagy following Vesicular 
stomatitis virus (VSV) infection. Silencing Toll-7 and Toll-2 during VSV infection in Drosophila 
S2 cells leads to an increase in the number of infected cells (62), suggesting the involvement of the 
pathway in antiviral protection. Inhibition of autophagy in Drosophila cells or adult flies has no 
effect on DCV replication (13), while it is yet to be determined whether this mechanisms is 
involved in controlling FHV infection. Removal of infected cells through autophagy likely inhibits 
viral replication due to the destruction of the host cell machinery components required for viral 
replication, however no direct evidence exist to confirm this hypothesis. 
Apoptosis 
Apoptosis is a regulated mode of cell death, and although is mainly known for its importance during 
development, it forms an important part of the innate immune response against viral infections (63-
66). Relatively little research has focused on understanding the effects of apoptosis on viral 
infections in Drosophila. Apoptosis has been implicated in the protection against two DNA viruses 
(Autographa californica multiple nucleopolyhedrovirus (AcMNPV) and Culex nigripalpus virus 
(CuniNPV)) and one RNA virus (FHV) (further details given below) (65-67). Although to date 
apoptosis has been implicated in protection only against AcMNPV, CuniNPV and FHV viruses, 
studies performed in human cells, shrimps, mosquitoes and Lepidoptera have shown the importance 
of apoptosis to extend beyond insects (68-71).  
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Antiviral mechanisms conclusion 
The study of antiviral responses in Drosophila is still relatively new and as we gain a better 
understanding of antiviral protection, we are likely to uncover new pathways responsible for 
protection against viral invasion. What is evident from studying antiviral responses in Drosophila is 
that in some cases multiple pathways are activated upon viral infection (Figure 1), and it is likely 
that antiviral pathways act in synergy to combat viral infection.  
Due to the recent evidence showing the impact of the route of viral entry on immune system 
regulation (15), importance should be given to try to understand the effects of the route of pathogen 
entry on the ability of the host to mount an immune response. Since the vast majority of studies 
focused on antiviral responses in Drosophila have been performed by injection, a considerable gap 
in knowledge exists in how the innate immune response is regulated in naturally infected 
populations. In the following section I focus on the importance of apoptosis as an innate immune 
mechanism. I will summarize and discuss the molecular mechanisms governing apoptosis in 
Drosophila in order to identify gaps in knowledge and introduce the reasoning behind the decision 
to expand on the scientific knowledge necessary to better understand the importance of apoptosis in 
antiviral defence.    
Apoptosis-mediated antiviral protection 
 
Apoptosis is a highly specific and regulated mode of cell death and inappropriate regulation of 
apoptosis can lead to a variety of diseases including autoimmune diseases, cancers and 
neurodegenerative disorders, demonstrating that it is essential for the organism to exert a high 
degree of control over apoptosis to ensure proper function (72). During apoptosis, a cell undergoes 
a physical transformation involving cytoplasmic shrinkage, blebbing of the plasma membrane, 
chromatin condensation, DNA fragmentation and swelling of the outer mitochondrial membrane, 
and culminates in the packaging of the cell for removal by phagocytosis (73, 74).  
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Apoptosis in Drosophila  
Apoptosis is essential for normal Drosophila development, it occurs as early as the 11th embryonic 
stage, and continues throughout embryogenesis (75). During pupation, apoptosis is essential for 
normal development of the eye, removal of the hindgut, larval muscles and salivary glands (76-78). 
 
Different signalling pathways exist which are involved in the induction of apoptosis in 
Drosophila, however they all ultimately converge through the transcriptional regulation of reaper 
(rpr), hid, grim and sickle (skl) (RHG) genes (Figure 2) (79`). Although the RHG genes share 
similarities, reaper, hid and grim are not functionally identical (80). The hid gene is essential for 
apoptosis of the midgut cells and salivary glands during metamorphosis and apoptosis of polar cells 
during oogenesis (81, 82). Grim is essential for the formation of the central nervous system midline 
and development of the eye (83), while rpr is involved in mitochondrial fusion during apoptosis, 
and has been implicated in the fly’s immune response to viral infection (65, 84).  
 
 
 
 
Figure 2: Apoptosis pathway in Drosophila. The core components of the apoptotic pathway in 
Drosophila. Viral infection can induce the transcription factor dP53, which requires the irradiation-
responsive enhancer region (IRER) to induce expression of the RHG genes (rpr, hid, grim and skl). 
Induction of the RHG genes induces autoubiquination and removal of DIAP1. Autoubiquination of 
DIAP1 releases the brakes on caspases (Dronc, Drice and Dcp-1), which become activated and lead 
to the induction of cell death. (Adapted from (85)). 
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The induction of the RHG genes often occurs through the transcriptional factor dP53, and 
requires the function of the irradiation-responsive enhancer region (IRER) (Figure 2) (65, 86, 87). 
Transcriptional activation of the RHG genes results in autoubiquination of the inhibitors of 
apoptosis (IAPs), which serve as breaks on apoptosis (88, 89).  
 
Inhibitors of apoptosis 
The first IAP was discovered in a baculovirus, and since its discovery, IAPs have been found in all 
major organisms (90, 91). IAPs inhibit apoptosis through binding and inhibition of caspases, which 
are known as the effectors of apoptosis (92, 93). Binding to caspases occurs through the baculovirus 
IAP repeat domain (BIR), which is required for the interaction with the RHG motif present on the 
RHG proteins (93, 94). A RING domain present on the IAPs is required for the E3 ubiquitin ligase 
function and is essential for targeting caspases (95-98), RHG proteins (99, 100) and other IAPs as 
well as themselves (101, 102) to ubiquitination. Four IAPs are present in Drosophila, Diap1, Diap2, 
dBruce and Deterin (reviewed in 80). The most widely studied IAP in Drosophila is the inhibitor-of 
apoptosis protein 1 (DIAP1), which plays a central role in the regulation of apoptosis (88). DIAP1 
is an E3 ubiquitin ligase that targets the degradation of caspases, a process necessary for preventing 
apoptosis from occurring spontaneously (103). Once the cell receives an apoptotic stimuli, an 
increase in transcription of the RHG genes leads to down-regulation of DIAP1, and activation of 
caspases.  
 
Caspases 
Cysteinyl aspartate proteinases, or more commonly known as caspases are a group of proteinases 
involved in apoptosis in several organisms (104). Drosophila has seven caspases that have been 
identified so far, DRICE, DRONC, DCP-1, DAMM, DECAY, DREDD and STRICA (for a review 
see 80). Caspases are synthesized in their inactive precursor form called zymogens, and protein 
cleavage is usually required for their activation (103, 105, 106). DRONC is known as a caspase 
activator, a primary initiator of caspase induced cell death, and is essential in regulating cell death 
during embryogenesis, larval development, metamorphosis and stress-induced apoptosis (85, 107). 
DRONC is kept in check by DIAP1, which can prevent DRONC processing and activation by 
ubiquitination (96). Following activation of DRONC, cleavage and activation of executioner 
caspase drICE, leading to cleavage of other substrates, ultimately culminating in cell death (89, 108, 
109). 
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Apoptosis as a host defence mechanism  
Induction of apoptosis during the early stages of pathogen infection can in some circumstances slow 
down pathogen replication and spread (65). To avoid this, viruses and other pathogens have evolved 
ways to manipulate apoptosis to their advantage. The evolutionary race between viruses and other 
organisms has often led viruses to evade the immune systems, with P53 often emerging as a target 
(65, 110, 111). For example the human papillomavirus (HPV) protein E7 can block P53-induced 
apoptosis, leading to immortalization of infected cells, and successful viral infection (112). 
Similarly, the adenovirus protein E4-ORF3 inhibits P53 expression by promoting heterochromatin 
formation at the P53 promoter, which ensures that infected cells do not undergo apoptosis, therefore 
allowing the virus to use the host machinery to its own advantage (111). 
 
 In Drosophila, induction of apoptosis during the early stages of FHV and CuniNPV 
infection can limit viral replication (65, 66). Injecting either FHV or CuniNPV into adult flies leads 
to dP53 and rpr up-regulation. Higher levels of rpr lead to the depletion of DIAP1 and activation of 
caspases, ultimately leading to cell death (Figure 2) (65, 66). In loss-of-function fly mutants with 
the transcriptional factor dP53 deleted, which would be expected to inhibit apoptosis, FHV is found 
in higher abundance compared to WT flies (65). Knocking-down DRONC in the fat body using 
RNAi, which would also be expected to inhibit apoptosis, lead to increased FHV replication 
suggesting that induction of apoptosis during the early stages of infection aids in removal of the 
virus (65).  
 
 While the effects of apoptosis on FHV abundance following viral injection have been 
demonstrated, it is not yet clear whether induction of apoptosis has an impact on survival of the 
organism. Furthermore, the involvement of apoptosis in protection against oral FHV infection has 
not yet been determined, therefore it is not clear whether apoptosis-mediated protection is 
dependent on the route of virus infection.  
 
Wolbachia 
While host-derived defence mechanisms are important for mediating antiviral protection, symbiotic 
relationships between hosts and bacteria can be just as important. An example is the interaction 
between the endosymbiotic bacteria Wolbachia pipientis and its Drosophila host. Wolbachia is a 
maternally transmitted intracellular endosymbiotic alpha-proteobacteria (family Rickettsiaceae) 
found in approximately 40 % of all arthropods and nematodes (113). It was first discovered in 1924 
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in the mosquito Culex pipiens, due to the incompatible crosses it caused (114). Wolbachia can cause 
sexual parasitism through cytoplasmic incompatibility, male killing and feminization of genetic 
males (115). Cytoplasmic incompatibility has perhaps been the most widely studied Wolbachia 
effect, and leads to non-viable offspring when Wolbachia infected males are mated with Wolbachia 
free females, while reciprocal crosses produce viable offspring (116, 117). These sexual parasitism 
effects lead to quick Wolbachia fixation in natural insect populations, leading to large geographical 
abundance of the bacterium. 
 
Wolbachia can form three types of symbiotic relationships in insects: (1) obligate 
mutualism, in which both organisms require each other for survival. An example of this is the 
interaction between Wolbachia and the wasp Asobara tabida, where Wolbachia plays and essential 
role in host reproduction, as removing the bacterium using tetracycline inhibits oogenesis (118). (2) 
Parasitism, in which one organism benefits at the expense of the other. In both Drosophila and 
mosquitoes, Wolbachia can act as a parasitic symbiont due to its life shortening and reproductive 
parasitism effects it exerts on its host (115, 119, 120). (3) Facultative mutualism, where an 
organism provides protection against another invading organism. The focus in this thesis will be on 
Wolbachia’s role as a facultative mutualist, due to the protective role it plays in the tripartite 
Drosophila-Wolbachia-virus interaction.  
 
Wolbachia-mediated antiviral protection in Drosophila 
The protective effect of Wolbachia was first discovered in the Drosophila host, where it was shown 
to delay mortality induced by infection with several RNA viruses such as DCV, FHV and CrPV, 
but not against a DNA virus IIV-6 (14, 32). Further studies performed in Drosophila found 
Wolbachia-mediated protection not to be confined to the abovementioned viruses, but that 
protection extends to a diverse range of viruses such as bluetongue and dengue viruses (121, 122). 
Presence of Wolbachia in Drosophila injected with DCV or FHV is often associated with reduced 
viral accumulation and increased lifespan compared to Wolbachia-free flies (Figure 3) (14, 32), 
however that is not always the case, as not all Drosophila-Wolbachia associations are protective 
against virus infection. The Wolbachia strains wMelCS, wRi, wAu, wMel and wMelPop, confer 
protection against DCV-induced mortality following DCV injection into adult flies, while the 
Wolbachia strains wNo and DSH-wHa do not (14, 32, 123, 124). The protective Drosophila-
Wolbachia associations can be further categorized depending on whether they confer protection 
against viral accumulation (resistance) or fly survival (tolerance). For example, the Wolbachia 
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strain wRi confers tolerance to DVC infection, however does not have a protective effect on viral 
accumulation (resistance) (123). Several other studies have shown that differences in resistance and 
tolerance exist in different Drosophila-Wolbachia associations (14, 125, 126), however it is yet to 
be determined whether the molecular mechanisms underpinning viral resistance and tolerance are 
the same.   
 
 
 
 
Figure 3: Wolbachia-mediated protection in Drosophila. Schematic diagram representing 
Wolbachia-mediated protection in Drosophila following injection with DCV (A) or FHV (B). The 
blue lines represent the survival of flies with Wolbachia, while the purple lines represent 
Wolbachia-free flies. The x-axis represents time post injection, while the y-axis represents 
percentage of survival. This schematic diagram represents the protection outcome seen in many 
experiments. 
 
Wolbachia-mediated antiviral protection in mosquitoes 
Wolbachia-mediated protection is not confined to Drosophila, as it has been observed in Aedes 
aegypti and Aedes albopictus mosquitoes artificially infected with Wolbachia, where protection has 
been observed against important human pathogens such as dengue, chikungunya, West Nile virus 
and yellow fever virus (124, 127-139). In mosquitoes, Wolbachia protection is characterized by 
reduced viral accumulation and transmission, but generally does not affect host survival (140). Not 
all Wolbachia-mosquito associations lead to a protective phenotype, in fact Culex tarsalis 
mosquitoes artificially infected with wAlbA show higher West Nile virus infection rates compared 
to Wolbachia-free mosquitoes (141), suggesting that multiple mechanisms may be controlling viral 
resistance. 
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Wolbachia protection observed in artificially infected Ae. aegypti has provided a basis for 
utilizing this system in arboviral suppression studies in areas affected by medically important 
arboviruses (132). High rate of maternal transmission and strong cytoplasmic incompatibility 
facilitate the establishment of the bacterium within a population, making it a potentially viable 
option for controlling arboviral transmission. Since Wolbachia was first proposed as an efficient 
tool against arboviral transmission, several groups have begun programs targeted at releasing 
Wolbachia-infected mosquitoes in natural populations. The first of such releases occurred in 2011 
in Queensland (Australia), where wMel infected Ae. aegypti mosquitoes successfully invaded two 
local Ae. aegypti populations (132). Since then, several releases have taken place in Australia, 
Indonesia, Vietnam, Brazil and most recently Colombia (www.eliminatedengue.org).  
 
Mechanisms of Wolbachia protection 
The mechanism through which Wolbachia mediates resistance and/or tolerance is not yet fully 
understood, however some mechanisms have been suggested to be important. Evidence exists for 
the involvement of miRNAs (142, 143), competition for host-derived resources (144) and elevated 
reactive oxygen species (145, 146) in antiviral protection, however the exact molecular mechanisms 
through which this pathways act are not yet clearly understood. Immune stimulation in mosquitoes 
artificially transinfected with Wolbachia has been proposed as a mechanism of Wolbachia 
protection (147), however no immune stimulation is observed in Drosophila naturally infected with 
Wolbachia (124, 148, 149), casting doubt on the involvement of the immune system on Wolbachia-
mediated protection. One thing that all protective Wolbachia strains share is high density within 
their respective organism, suggesting that high Wolbachia density may serve as a prerequisite for 
antiviral protection (123, 125-127, 131, 139, 150, 151). Gradually reducing Wolbachia density in 
both Drosophila adults and mosquito cell culture using tetracycline leads to a dose dependent loss 
of antiviral protection (131, 150), further supporting the importance of density. While the 
importance of Wolbachia density has been demonstrated in adult flies and mosquitoes, no study to 
date has determined the importance Wolbachia density in larvae or assessed the effect of Wolbachia 
on antiviral protection in larvae. 
  
Impact of Wolbachia-mediated protection on viral dynamics  
One of the most interesting aspects of Wolbachia-mediated protection is the effect Wolbachia has 
on natural viral dynamics. By interfering with viral replication, Wolbachia can decrease the 
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transmission of arboviruses such as dengue and chikungunya in its mosquito host (127, 129, 135, 
137). Decreasing transmission of arboviruses would likely decrease the number of infected human 
hosts, which in turn would have a negative impact on circulation of arboviruses in natural 
populations. A recent study suggested that as much as a fifth of all arthropod species may benefit 
from Wolbachia-mediated protection (126), therefore the impact of Wolbachia on viral circulation 
in natural arthropod populations could be significant. The effect of Wolbachia on natural viral 
dynamics is hard to predict due to a range of factors influencing viral transmission. Modelling 
studies have identified factors such as reproduction rate, death rate, maturation rate and Wolbachia 
transmission rate as factors important in controlling dengue transmission dynamics (152-154). 
While a range of factors influencing viral transmission in the presence of Wolbachia have been 
identified, the effects of life-stage susceptibility on virus dynamics have not yet been considered. 
 
Both Drosophila and mosquitoes are holometabolous insects, undergoing metamorphosis 
between larval and adult stages. A wide range of genes coordinate the disintegration of larval 
structures, where some larval organs are histolysed and major new growth takes place, altering the 
morphology and in some cases pathogen susceptibility (155-157). Differences in life-stage 
susceptibility could have an impact on the host’s ability to survive and transmit the infection, which 
could affect viral dynamics. Studies in insects such as Chrysodeixis chalcites, Lymantria dispar and 
Lepidoptera Noctuidae have shown that viral susceptibility can vary throughout the life-stages (158-
160), raising the question whether Wolbachia protection in Drosophila and mosquitoes could be 
life-stage dependent. Studies concerned with Wolbachia-mediated protection in both flies and 
mosquitoes have to date been performed solely on adults without consideration of other 
developmental stages. Furthermore, comparison between Drosophila and mosquito studies could be 
confounded by the fact that different routes of infection were used in the studies. Studies performed 
on mosquitoes utilized ingestion of contaminated blood-meal as a viral delivery method, whereas 
studies in Drosophila utilized intra-thoracic injections. Viral injections bypass the fly’s natural 
immune barriers present within the midgut, and can cause a differential immune response compared 
to virus feeding alone (15). It is yet to be determined whether the molecular mechanisms behind 
Wolbachia protection are dependent on the route of infection and whether similar molecular 
mechanisms control protection in Drosophila and mosquitoes. Studies on orally infected 
Drosophila could facilitate comparisons between flies and mosquitoes, and could be used to further 
characterize Wolbachia protection mechanisms.  
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Aims of thesis 
 
Antiviral defence is of great importance for many organisms, as the ability of an organism to mount 
an antiviral response can affect host survival and virus dispersal. Recent studies showed that the 
route of pathogen entry can influence immune regulation, which lead to a renewed interest in the 
effect of a natural route of infection on immune regulation. The aim of this thesis was to utilize the 
oral route of virus infection to study Drosophila’s antiviral responses in an effort of gaining a 
greater understanding on immune regulation in natural insect populations.  
 
Aim 1 To develop a tool able to detect active Drosophila C virus replication and characterize the 
impact of the route of infection on the outcome of Drosophila C virus infection.  
 
Aim 2 To determine Wolbachia-mediated protection at larval and adult developmental stages 
following the oral route of virus infection. 
 
Aim 3 To study the effect of apoptosis on Flock House virus infection following the oral and 
systemic routes of infection. 
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Chapter 2: Infectivity of Drosophila C virus following oral 
delivery in Drosophila larvae
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Abstract 
 
The route of pathogen entry can have a major effect on the ability of the virus to induce a prolific 
infection, but it can also affect the ability of the host organism to induce an immune response to 
fight the infection. Transmission of arboviruses that cause serious diseases in humans often begin 
by an insect ingesting a virus, which then disseminates through the internal organs and tissues and 
ultimately culminates in viral transmission to a human host. Understanding the effect of a natural 
route of infection on the host-pathogen interaction may facilitate development of approaches to 
prevent viral dissemination. Drosophila has been a useful model organism for understanding host-
virus interactions, however most studies have achieved infection by artificially injecting the virus 
into the host. Here we develop a single-stranded quantitative PCR able to detect only actively 
replicating Drosophila C virus (DCV) to study the effect of viral feeding at the early stages of larval 
development. Exposure of newly hatched larvae to DCV leads to 20 % of larvae becoming infected 
within 12 hours post-contamination, and causes a 14 % egg to adult mortality. Using the newly 
developed tools, the results show for the first time that DCV is able to establish a prolific infection 
following larval feeding, and suggests that larvae that become infected die before adult eclosion.  
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Introduction 
 
Exposure of insects to pathogens can occur via different routes, which can have important impacts 
on the outcome of the infection. Arthropod-borne viruses are commonly transmitted horizontally 
through oral infection (1), while other insect viruses can be transmitted vertically and/or 
horizontally (reviewed in 2). Differential immune responses may exist depending on the route of 
pathogen entry (3, 4), however this is an area that has been largely unexplored. In Drosophila, 
different routes of viral infection can trigger differential physiological responses, and can influence 
the host’s adaptation to the pathogen (5).  
 
Drosophila is a strong model for insect host-virus interactions and Drosophila C virus 
(DCV) is commonly utilised in studies of interactions and host defense mechanisms in Drosophila 
(6-11). DCV is a member of the Dicistroviridae family of viruses, and is the most well studied 
Drosophila virus (2, 12). DCV is a non-enveloped, single-stranded positive sense RNA virus with a 
genome comprising of 9264 nucleotides (13). During active viral replication DCV replicates its 
genome by synthesizing negative sense RNA, which is used as a template to produce more positive 
sense RNA (14). The negative strand RNA is not encapsidated in virus particles and can only be 
detected in cells with actively replicating virus, therefore making it a useful feature for studying 
viral infection.  
 
While DCV is one of the best-characterized Drosophila viruses, the natural route of 
infection is poorly characterized (15). Most studies involving DCV have utilized injection, while 
the natural route of infection has largely been unexplored. One of the benefits of injecting DCV into 
its host is that the virus induces mortality within 4-6 days post-injection (8, 16), a system that has 
been widely used to study the innate immune response in Drosophila (17), and the effect of the 
bacterial endosymbiont Wolbachia on antiviral protection (18). 
 
Injecting the virus bypasses the fly’s natural midgut protection barriers, and can initiate a 
differential immune response compared to viral feeding alone (4, 5). While systemic DCV 
infections provide a useful model, the natural route of infection is likely to occur through ingestion 
of virus-contaminated food (19). Depending on the route of infection and developmental stage, 
DCV may exhibit different tissue tropism. Following injection of DCV into adult flies the virus 
spreads to the trachea, fat body, somatic muscles, visceral muscles along the midgut, and the 
epithelial sheath surrounding the egg chamber (7, 20). In contrast, reports have suggested that 
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following ingestion of DCV from the first larval instar the virus is confined to the lumen of the 
digestive tract and the basal part of gut cells (21). 
 
Here we show that larvae fed on DCV-contaminated food do not become persistently 
infected by the virus, but rather that flies which become infected likely succumb to the infection 
before adult eclosion. Furthermore we develop a single-stranded quantitative PCR (ssqPCR) able to 
differentiate between active viral replication and the presence of non-replicating virus, a feature 
which can be a useful to study DCV infection dynamics.  
 
Materials and Methods  
Virus and flies 
Plaque purified DCV isolate EB (8, 22) was propagated and purified from Schneider’s Drosophila 
Line 2 cells (23) and virus titres were determined by 50% tissue culture infectious dose (TCID50) as 
previously described (8, 24). Flies were reared on standard cornmeal media, at a constant 
temperature of 25°C with a 12-hour light/dark cycle. The rearing media was composed of 8.75 % 
cornmeal, 1.5 % yeast extract, 7.5 % agar, 0.3 % propionic acid and 0.3 % tegosept solution, while 
the rest was composed of water. The D. melanogaster line Oregon RC (ORC) was used in the 
experiments, which has been previously cured of Wolbachia (ORC-T) by tetracycline treatment 
(25). 
 
RNA extraction, cDNA synthesis and qPCR  
RNA was extracted from either larvae or adult flies. The insect samples were frozen and 
homogenized in Ribozol TM (Amresco) with two 3 mm glass beads using TissueLyser II (Qiagen) 
for 90 seconds at 30 Hz. The total RNA was precipitated from Ribozol and the samples were treated 
with DNase (Promega) at 30 minutes at 37°C. 1 µg of total RNA was reverse transcribed using 
either DCV-tag or rpL32-R primers (Table 2). The primers were used at a total concentration of 500 
nM, and were incubated along with RNA at 65°C for 5 min before being set on ice for 1 minute. 
cDNA was synthesized using SuperScript III reverse transcriptase (Invitrogen) at 55°C for 60 min, 
and then heat inactivated at 95°C for 15 min. For quantitative PCR analysis Platinum SYBR® Green 
qPCR SuperMix-UDG (Invitrogen) was used as per manufacturer’s instruction using Tag / DCV-R 
or rpL32-F / rpL32-R primer pairs (Table 2). The Rotor-
 38 
Sciences, Qiagene) was used with the following profile: 95˚C 2 minutes, followed by 40 cycles of 
95˚C 10 seconds, 60˚C 10 seconds and 72˚C for 20 seconds. This was followed by a standard melt 
analysis to confirm that only the expected product had been amplified.  
 
Strand-specific assay 
To generate standard curves for ssqPCR, a 546 bp portion of the DCVEB genome (ORF1 from 3788 
bp to 4333 bp) (13) was reverse transcribed using the DCV1-rv primer (Table 2) as above. 
Following reverse transcription, a PCR was performed using Taq polymerase (New England 
biolabs) and the DCV-F / DCV1-R primer pair (Table 2) was used under the following PCR 
conditions: 95˚C 30 seconds followed by 35 cycles of 95˚C 20 seconds, 58˚C 30 seconds and 68˚C 
for 40 seconds. The PCR reaction was run on a 1.5 % agarose gel, the DCV fragment was excised 
from the gel and the DNA was purified using QIAquick gel extraction kit (Qiagen). Subsequently 
the purified fragment was cloned in both directions into a pGEM-T easy vector (Promega). The 
viral positive and negative RNA strands were transcribed using T7 RNA polymerase (Megascript) 
from SacI digested plasmid with the insert oriented in the sense and antisense directions 
respectively. The RNA transcripts were purified using RibozolTM (Amresco), and the samples were 
treated with DNAse as described above. The concentration of the transcripts was determined by 
spectrophotometry (Epoh, BioTek). The cloned DCV fragment has a molecular mass of 215,895 g 
mol-1, and one microgram of RNA contains approximately 2.7 x 1012 strands of RNA.  
 
Larval bioassay 
Flies were anaesthetised with CO2 prior to infection. Drosophila flies were injected with 5000 DCV 
infectious units (IU) using a Nanoject II microinjector (Drummond Scientific) as previously 
described (8). Flies that died within the first 24 hours were considered to be dead due to the needle 
injury and removed from the vials. Flies were collected at 4 days post-injection and stored at -20°C 
until further use. Thirty individual flies were pooled and ground in 600 µl of PBS using two 3 mm 
glass beads in a TyssueLyser II (Quiagen) at 30 Hz for 60 seconds. The debris was removed by 
centrifugation at 14,000 RPM for 10 minutes, and the supernatant was filter sterilized to remove 
bacteria using a Millex GV 22 µm filter (Merck Millipore). Following filtration, the suspension was 
spread immediately onto bottles containing standard cornmeal media for larval feeding bioassays.  
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To determine whether flies feeding on DCV from the first larval instar become infected, adult 4-7 
day old ORC flies were transferred to vials containing fresh Drosophila food and the following 
morning 100 eggs were collected, placed on wet sterile filter paper, and transferred into bottles 
containing extracts of either PBS or DCV injected flies. The hatched larvae were maintained on the 
treatment media until collection. Samples were collected at larval stages for ssqPCR analysis, or at 
4 days post-adult eclosion for survival bioassay analysis.  
 
Larval survival from embryo to adulthood was determined following the larval bioassay to 
determine if viral feeding at larval stages causes and increase in mortality. Larval mortality was 
calculated as a percentage of adults post-eclosion compared to the number of eggs before the 
treatment. Statistical analysis was performed using an unpaired two-tailed Student’s t-test assuming 
equal variance. 
 
Time-course of DCV infection 
100 eggs were added to each of four bottles containing DCV-contaminated media. 20 individual 
larvae were collected at 12, 24, 48 and 72 hours post-contamination, RNA was extracted and the 
ssqPCR was performed to determine if the larvae became infected.  
 
Survival bioassays 
Following larval feeding, adults were collected 4 days post-eclosion in order to determine if they 
became infectious. Five adult flies were pooled, homogenized, and fly extracts were prepared as 
above. For each treatment, 15 flies were injected with the extracts and daily mortality was scored. 
Mortality that occurred on the first day post-injection was considered to be due to needle injury. 
Three replicates of the larval feeding were performed for each group using independent cohorts of 
flies.  
Results 
Egg to adult mortality 
To understand the dynamics of DCV infection in larvae, we investigated the effect of viral feeding 
on egg to adult mortality. Briefly, 300 eggs across 3 different cohorts (100 eggs each) were added to 
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either phosphate buffered saline (PBS) or DCV-contaminated media and mortality rates were 
determined post-adult eclosion. A significantly higher egg to adult mortality (44 %) was observed 
in the DCV treatment group compared to the control group (30 %, p < 0.001, Figure 1). The results 
indicate exposure to virus as larvae leads to infection and an increase in mortality.  
 
 
Figure 1. Egg to adult mortality following viral challenge per os. Larvae challenged with DCV 
show a significantly higher mortality compared to the control PBS group. Statistical analysis using 
an unpaired two-tailed Student’s t-test assuming equal variance indicates that these groups are 
significantly different (p < 0.001).  
 
Adult infectivity 
Since natural infections are likely to occur by ingesting contaminated food, we were interested to 
know whether the surviving adults emerging from larvae fed on contaminated media were 
infectious. In this experiment first instar larvae were exposed to PBS or DCV-contaminated media 
until 4 days post-adult eclosion. These flies were defined as the F0 generation. Following 
emergence flies were homogenised and extracts were injected into DCV free flies. Homogenates of 
flies reared on PBS induced negligible mortality, with over 90% of the flies surviving 15 days post-
injection (Figure 2a). In contrast, the homogenates of flies reared on DCV-contaminated media 
induced 100% mortality within 7 days post-injection (Figure 2a). The data indicates that a high 
level of DCV is associated with the F0 population following viral feeding. 
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Figure 2. Analysis of infection status of flies exposed to DCV as larvae. Drosophila were 
exposed to virus through all larval stages and collected after adult eclosion. Gray dashed lines 
represent flies exposed to PBS, while black lines represent flies exposed to DCV. All experiments 
have been performed in triplicates. (a) Homogenates of F0 generation flies exposed to DCV during 
larval stages are highly pathogenic when injected into DCV free flies. (b) Homogenates from the F1 
generation flies from either PBS or DCV groups were not pathogenic when injected into DCV free 
flies. 
 
To determine whether the virus associated with the F0 flies is passed on to the following 
generation (F1), the F1 fly extracts were injected into DCV free flies. The homogenates of neither 
PBS nor DCV groups caused any significant mortality in the injected flies (Figure 2b). The results 
suggest that the F1 generation carried little or no infectious virus, indicating that DCV was lost 
between the F0 and F1 generation. Possible interpretations of these results are that: the flies were 
infected with virus during the F0 generation but that the virus was lost by the time of the assay of 
the F1 generation; or that the F0 flies were associated with virus through the process of feeding, but 
that the virus had not infected the flies.  
 
Single-stranded qPCR assay 
To test whether the flies were infected during the F0 generation and cleared the infection by F1, or 
if the virus was merely associated with the flies without causing an infection in F0 flies, we 
developed a ssqPCR. The ssqPCR detects actively replicating virus, by being able to distinguish 
between positive and negative sense viral RNA. Detecting the negative sense RNA is indicative of 
actively replicating virus (26, 27). Presence of both the viral positive and negative sense RNA 
strands during standard qPCR can cause both RNA strands to be detected even if cDNA synthesis is 
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performed using a strand-specific primer (28). To ensure specific detection we designed a tagged 
primer which incorporates a tag sequence into cDNA during synthesis from the negative strand 
template (28-33). The tag sequence added during cDNA synthesis is composed of a 20-nucleotide 
long tag sequence that carries no sequence homology to either the virus or host organism. The 
presence of tagged cDNAs can be detected during qPCR, where a tag-specific forward primer, and 
virus-specific reverse primer are used to amplify the desired cDNA product. In absence of the tag 
sequence, the presence of the positive strand cDNA reduces the specificity of the ssqPCR (28). 
 
To determine the specificity of the ssqPCR, we performed analysis on positive and negative 
RNA strands of DCV. When 4x106 copies of the negative sense RNA were reverse transcribed 
using the DCV-tag primer (Table 2) the ssqPCR showed amplification at the 20th cycle, however 
when 4x106 copies of the positive sense RNA were reverse transcribed using the same primer there 
was no observable amplification by ssqPCR (data not shown). These results indicate that the 
ssqPCR is able to discern between the positive and negative strands of viral RNA, making it a 
useful tool for studying DCV replication. 
  
A standard curve was performed to determine the amplification efficiency and detection 
limits of the assay. The standard curve was generated using ssqPCR by 5-fold serially diluting 1.6 x 
107 copies of negative sense RNA strand until the detection limit was reached. The standard curve 
generated by the assay has a slope of -3.446, R2 of 0.9993 and amplification efficiency of 95.6% 
(Figure 3a). The lowest dilution the assay could detect reliably was 1 x 103 copies of negative sense 
RNA. The high R2 and amplification efficiency values suggest that the assay has a high dynamic 
range of detection (between 1 x 103  - 1.6 x 107 copies of negative sense RNA) and that using this 
assay, the standard curve can be used to accurately calculate the absolute number of negative sense 
RNA strands present within a sample. 
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Figure 3. (a) Standard curves generated using qPCR on serially diluted negative sense RNA 
strands. The x-axis represents the Log10 of the absolute number of negative RNA strands present 
before reverse transcription, while the y-axis shows the cycle threshold value (CT), which represents 
the number of PCR cycles required for the fluorescent signal to cross a specified threshold value. 
(b) Absolute amount of negative sense RNA strands detected in a homogenized sample of 30 adult 
flies injected with 5000 IU of DCV compared to adult flies fed with DCV from the first larval 
instar. 
 
DCV replication detection following viral feeding 
Using the ssqPCR we analysed the DCV infection status of the F0 and F1 generation flies. Analysis 
of positive control flies injected with DCV detected high numbers of negative sense RNA (approx. 
2.5 x 105) 4 days post-injection, in contrast, no amplification was detected in either the F0 or F1 
generations (Figure 3b). The ssqPCR data suggests that following eclosion, larvae feeding on DCV-
contaminated media do not become persistently infected by the virus.  
 
DCV infection dynamics during larval stages  
While there was an increase in egg to adult mortality, 56 % of flies did not succumb to the 
infection, posing the question whether the surviving larvae were getting infected and recovering, 
were tolerant to the infection or whether only a small percentage of flies were infected and dying. 
To address this question, we performed a ssqPCR on individual larvae feeding on DCV infected 
media for 12, 24, 48 or 72 hours post-larval hatching. At 12 hours post-larval feeding 20 % of 
larvae showed actively replicating virus, at 24 hours 10 % of larvae showed actively replicating 
virus, while at 48 and 72 hours our assay did not detect active viral replication (Table 1). These 
results show that larvae fed on DCV-contaminated media can become infected by the virus. DCV 
replication is detected only in the first 24 hours post-viral ingestion, suggesting that larvae are 
susceptible to the virus in the first 24 hours post-embryonic development, and that not all the larvae 
become infected following viral feeding. While no virus replication was detected past 24 hours 
post-ingestion, it is possible that viral replication was occurring but at levels below ssqPCR 
detection. 
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Discussion 
While the mechanism of DCV infection in nature is not entirely understood, it has been reported 
that DCV does not transmit transovarially, but rather horizontally (19). It has been suggested that 
DCV can infect its host through direct contact with feces and cadavers (34). In this paper we set out 
to understand the impact of viral feeding at the early stages of development in Drosophila. 
Following viral feeding we observed an increase in egg to adult mortality, which was associated to 
the presence of virus. While an increase in mortality was noted, a large proportion of larvae 
survived to adulthood, posing the question whether the flies reaching adulthood were not infected, 
recovered from infection, or whether they were tolerant to the virus. DCV is known to be present in 
natural Drosophila populations (35, 36), therefore we hypothesized that flies which survived to 
adulthood would be infected. However, while homogenates of F0 generation were highly 
pathogenic (Figure 2a), the pathogenicity was lost in the following F1 generation (Figure 2b). This 
led to the question of whether the infectivity of the F0 generation was due to a viral infection 
present within the population, or whether the virus was simply associated with the flies due to direct 
contact through feeding, without yielding a productive infection. Using a ssqPCR, we failed to 
detect active viral replication in either F0 or F1 generations, indicating that the infectivity of the F0 
population was likely due to virus associated with the flies through feeding rather than a systemic 
infection.  
 
There are a number of possibilities that may explain why DCV induces mortality at the 
larval stages but does not persist in adults, these include: 1. not all larvae get exposed to the virus, 
therefore the flies that are exposed to the virus during the larval stages die before adult eclosion, 
while larvae that are not exposed to the virus survive to adulthood; 2. larvae are coming in contact 
with the virus, but a viral threshold exists beyond which larvae become infected and die, while 
below the threshold the larvae do not become infected or recover quickly from infection; 3. there 
are differences in susceptibility between larvae. While it is possible that not all larvae get exposed 
to the virus during feeding, we suggest that this scenario is unlikely, as the viral homogenate is 
evenly dispersed on the whole feeding surface, and insects are placed on the media at the egg stage, 
and would therefore have to avoid DCV in the media during feeding. Note that the percentage of 
egg to adult mortality (14 %) (Figure 1) is similar to the percentage of larvae found to be infected at 
12 (20 %) and 24 hours (10 %) post-emergence (Table 1) which suggests that larvae that become 
infected within the first 24 hours die before adult eclosion. The remaining ~80 % of flies are either 
not becoming infected or quickly controlling the infection and recovering before 12 hours post-
larval feeding, however there is no evidence to support either of these two alternatives. Our results 
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show that susceptibility occurs at the very early stages post-hatching and indicates that larvae that 
become infected die before adult emergence. 
 
The reason behind low DCV infectivity through ingestion has not yet been elucidated, as 
most viral studies have not considered the natural route of infection. Most pathogen-host 
interactions in nature do not result in a prolific infection (37), which is likely due to the protective 
gut barrier present in the host organism. Epithelia in the gut function as both physical and chemical 
barriers to pathogen entry, and following ingestion the pathogen is required to cross the epithelial 
surface in order to induce a prolific infection (38-41). Expression of AMPs in the gut forms part of 
the systemic immune response, which alongside reactive oxygen species is used by the fly to fight 
off bacterial infections (reviewed in 38). The immune response in the gut is not confined to the 
defense against bacteria, but it can also form a protective barrier against viral infections (4, 42-44). 
Insects challenged orally by viruses induce or down-regulate the ERK and JAK-STAT pathways, 
which are required to limit viral infection (42, 43, 45). A recent study showed the importance of the 
Toll pathway on antiviral immunity following viral feeding in adult Drosophila (4). Adult flies 
feeding on the highest viral dose show up to 25 % mortality. With no significant mortality occurring 
past 8 days post-infection, it would be interesting to determine whether the remaining 75 % of flies 
become infected and are tolerant to the virus, or whether similarly to larval feeding, only a small 
percentage of flies become infected. 
 
Differences clearly exist between the route of DCV entry and the effect of the virus on the 
host. Route of DCV entry effects the adaptation of the host to the virus (5), the induction of the 
hosts immune system (4), and the ability of the virus to induce a prolific infection. We showed 
using the ssqPCR that DCV can cause a prolific infection following larval ingestion, however a 
large number of uninfected larvae suggests that protection mechanisms exist within the host which 
are either able to prevent the infection from occurring or are able to clear the infection early in the 
infection cycle, a feature which is not observed following viral injection. Persistent viral infections 
in nature occur either by a different route of infection, or there are other parameters which we don’t 
yet understand influencing the establishment of a persistent DCV infection in Drosophila. The 
ssqPCR described here could be used in future research to study the dynamics of DCV infection, 
and to determine whether a similar infection dynamics is present in adult flies post-viral feeding. 
Using the larval model of infection, important immune regulation mechanism could be elucidated, 
which would be useful for understanding host-pathogen interactions in medically important 
arboviruses. 
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Tables 
Table 1. Detection of actively replicating DCV in larvae following feeding. 
Time post- 
infection 
Total number of 
larvae 
Number of larvae 
infected 
% larvae 
infected 
12 h 20 4 20 
24 h 20 2 10 
48 h 20 0 0 
72 h 20 0 0 
 
 
Table 2. Sequence of primers used for reverse transcription (RT), quantitative PCR (qPCR) 
and cloning. 
 
Primer 
name Nucleotide sequence (5’→3’) Purpose Reference 
Tag AATTCAAGCTCGTCTTCCTCG qPCR This study 
DCV-R AATGGCAAGCGCACACAATTA  qPCR This study 
DCV-tag AATTCAAGCTCGTCTTCCTCGAGGCTGTGTTTGCGCGAAG RT This study 
DCV1-R CTTCTGCATCATTTCCAGCA  cloning This study 
DCV-F AGGCTGTGTTTGCGCGAAG cloning This study 
rpL32-F GACGCTTCAAGGGACAGTATCTG qPCR (8) 
rpL32-R AAACGCGGTTCTGCATGAG qPCR (8) 
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Chapter 3: Wolbachia-mediated antiviral protection in Drosophila 
larvae and adults following oral infection 
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Abstract 
 
Understanding viral dynamics in arthropods is of great importance when designing models to 
describe how viral spread will influence arthropod populations. The endosymbiotic bacterium 
Wolbachia, which is present in up to 40% of all insect species, has the ability to alter viral dynamics 
in both Drosophila and mosquitoes, a feature that in mosquitoes may be utilised to limit spread of 
important arboviruses. To understand the potential effect of Wolbachia on viral dynamics in nature, 
it is important to consider the impact of natural routes of virus infection on Wolbachia antiviral 
effects. Using adult Drosophila we show that Drosophila-Wolbachia associations that have 
previously been shown to confer antiviral protection following systemic viral infection also confer 
protection against viral-induced mortality following the oral route of Drosophila C virus infection in 
adults. Interestingly, a different pattern was observed when the same fly lines were challenged with 
virus as larvae. Analysis of the four Drosophila-Wolbachia associations that were protective in 
adults, indicated that only the w1118-wMelPop conferred protection in larvae following oral delivery 
of the virus. Analysis of Wolbachia density using qPCR showed that high Wolbachia density was 
congruent with antiviral protection in both adults and larvae. This study indicates that Wolbachia-
mediated protection may vary between larval and adult stages of a given Wolbachia-host 
association, and that the variation in life-stages susceptibility corresponds with Wolbachia density. 
The differences in the outcome of virus infection is likely to influence viral dynamics in Wolbachia-
infected insect populations in nature, and could also have important implications for the 
transmission of arboviruses in mosquito populations. 
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Introduction 
 
Arthropods harbour a wide range of viruses that can be transmitted between individuals or 
populations of the same species, or can bridge the interspecies gap to infect plants or other animals. 
The outcome of viral infections can be modulated by tripartite interactions between arthropods, 
viruses and bacteria (1). One such interaction is the tripartite interaction between insects, viruses 
and the endosymbyotic bacteria Wolbachia pipientis. 
  
Wolbachia has gained much attention due to the antiviral effects it confers to its host. The 
impact of Wolbachia on virus infection was first described in the Drosophila melanogaster host, 
where it was shown to protect against mortality induced by diverse viruses including Drosophila C 
virus (DCV), Cricket paralysis virus and Flock House virus (2, 3). Since that discovery, Wolbachia-
mediated antiviral effects have been demonstrated in a number of insect hosts, and are being 
investigated as a way of limiting spread of arboviruses (reviewed in 1, 4, 5, 6). Notably, Wolbachia-
mediated antiviral effects have been demonstrated in adult mosquitoes artificially infected with 
Wolbachia, where Wolbachia can interfere with accumulation and transmission of important human 
pathogens including dengue and chikungunya viruses (7-17). While in many cases Wolbachia 
confers antiviral effects to its host organism, in some cases the presence of Wolbachia can enhance 
viral susceptibility (18-23). The impact of the presence of Wolbachia on virus infection can include 
two main effects: 1) interference with viral replication/accumulation, and/or 2) protection against 
viral-induced mortality. In mosquitoes, Wolbachia interferes with viral replication/accumulation, 
while in Drosophila, Wolbachia can interfere with viral replication/accumulation and/or protect 
flies from viral-induced mortality. In this paper we will focus on the effect of Wolbachia on the 
survival of the host, and will define protection as a reduction/delay in viral-induced mortality.   
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The mechanisms involved in Wolbachia-mediated antiviral effects have not yet been fully 
elucidated. There is some evidence that miRNAs (24, 25), competition for host-derived resources 
(26) and elevated reactive oxygen species (27, 28) may influence antiviral effects. Drosophila-
Wolbachia associations can be subdivided into two groups, protective and non-protective. The 
Drosophila-Wolbachia pairings CO-wAu, DSR-wRi, w1118-wMel and the over-replicating and life-
shortening wMelPop in w1118 show a delay in DCV induced mortality when DCV is injected into 
adult flies, while N7NO-wNo and DSH-wHa do not (2, 3, 11, 29). A feature that all protective 
Wolbachia strains share is high density within their respective host organism, indicating that high 
Wolbachia density may serve as a prerequisite for antiviral protection (7, 12, 29-34).  
 
Wolbachia is estimated to infect 40 % of all insects (35), therefore the effect it exerts on 
natural viral dynamics could be pronounced. The understanding of natural tripartite Drosophila-
virus-Wolbachia interactions is very limited at present, partially due to a lack of a method of orally 
delivering virus. Recently, three methods for oral infection of larvae and adults were described, 
which will allow us to study the effects of the oral route of infection on antiviral protection 
mechanisms in Drosophila (36-38).  
 
To investigate the effects of Wolbachia on viral-induced mortality following the oral route 
of infection, we used DCV; a natural Drosophila pathogen and the most widely studied Drosophila 
virus (39). DCV is a positive-sense RNA virus belonging to the Dicistroviridae family (40). When 
injected into flies, DCV is pathogenic, causing mortality within 4-6 days post-injection (41). 
Injecting DCV is a useful method to study Wolbachia-DCV interactions, however injection 
bypasses the fly’s natural immune barriers present within the midgut, and can cause a differential 
immune response compared to virus feeding alone (37). DCV infection by ingestion is less 
pathogenic compared to injection (36, 37) and represents a more natural Drosophila-DCV 
interaction. While Wolbachia-mediated protection has been extensively studied in adult flies 
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following a systemic infection, it is not yet clear whether the Drosophila-Wolbachia associations 
that are protected from viral-induced host mortality following viral injection exhibit a similar 
protective characteristic following the oral route of infection. Ingesting infected cadavers is thought 
to be one of the mechanisms through which DCV transmission occurs naturally within a population 
(42), therefore Wolbachia-mediated antiviral protection following the oral route of infection could 
have a direct impact on viral transmission and maintenance of the virus within a population.  
 
Understanding the potential of Wolbachia to effect viral dynamics in natural populations 
will be facilitated by insight into the impact of antiviral protection on susceptibility throughout the 
life cycle of the host following a natural route of infection. Both Drosophila and mosquitoes are 
holometabolous insects, undergoing metamorphosis between larval and adult stages. A wide range 
of genes coordinate the disintegration of larval structures, where some larval organs are histolysed 
and major new growth takes place, altering the morphology and in some cases pathogen 
susceptibility (43-45). Pathogen susceptibility is often age or life-stage dependent and can have a 
large effect on population dynamics, viral spread and maintenance of the virus within the 
population (45-48). Studies focusing on the antiviral effects of Wolbachia have to date been 
conducted solely on adult flies and mosquitoes, without consideration of the other developmental 
stages.  
 
Here we investigate the effect of Wolbachia on viral-induced mortality of Drosophila larvae 
and adults following oral challenge with DCV. By using four Drosophila-Wolbachia associations 
that have previously been shown to be protective in adults following viral injection, we show that 
the Drosophila-Wolbachia associations that are protected against viral-induced mortality following 
injection, are also protected following oral infection of adults. In contrast, Wolbachia protection at 
the adult stages is not indicative of protection at larval stages, as only one out of four Drosophila-
Wolbachia associations that are protective at the adult stages show protection at the larval stages. 
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Materials and methods 
Drosophila and Wolbachia 
Two D. melanogaster and three D. simulans fly lines were reared on a standard cornmeal media at a 
constant temperature of 25°C with a 12-hour light/dark cycle. Paired populations of flies were used 
that either contained Wolbachia (w1118-wMel, w1118-wMelPop, N7NO-wNo, DSR-wRi, Co-wAu), or 
have been cured of Wolbachia by tetracycline treatment (w1118-T, N7NO-T, DSR-T and CO-T), and 
maintained on a standard cornmeal media for at least five generations before use. Gut flora was 
reconstituted and normalised across fly lines using standardised methods (31). Briefly, Drosophila 
embryos were transferred to vials containing 150 µl of a bacterial inoculum, which was prepared by 
adding 2 g of 10 days old food containing w1118-wMelPop flies to 5 ml of sterile water and strained 
through a fine sterile mesh to remove larvae and embryos. The newly treated flies were checked for 
the presence of Wolbachia using PCR, to make sure that no cross-contamination had occurred.  
 
Virus 
Plaque-purified DCV isolate EB (49, 50) was propagated and purified from Schneider’s Drosophila 
Line 2 cells (51), and virus titres were determined by tissue culture infective dose (TCID50) as 
described previously (29, 49).  
DNA extraction 
Thirty 0-4 hour old larvae or ten newly emerged male adult flies were pooled to perform DNA 
extraction. The flies were homogenized using a pestle in 180 µl of extraction buffer and 20 µl of 
proteinase K. The DNeasy Blood & Tissue kit (Qiagen) was used to extract the DNA as per the 
manufacturer’s protocol. Three replicates on independent cohorts were performed for each 
treatment. 
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Quantitative PCR 
The abundance of Wolbachia was determined by qPCR by quantifying the abundance of the 
Wolbachia surface protein (WSP) relative to either the D. melanogaster RrpL32 or D. simulans 
Act5C genes. Platinum SYBR® Green qPCR SuperMix-UDG (Invitrogen) was used as per 
manufacturer’s instruction using the WSP specific primer pair 5’- 
GCATTTGGTTAYAAAATGGACGA-3’ and 5’- GGAGTGATAGGCATATCTTCAAT-3’ 
(producing a 185 bp PCR product) (29), RpL32 specific 5’- GACGCTTCAAGGGACAGTATCTG-
3’ and 5’-AAACGCGGTTCTGCATGAG-3’ (producing a 141 bp PCR product) (49) and Act5C 5’-
GACGAAGAAGTTGCTGCTCTGGTT 
G-3’ and 5’-TGAGGATACCACGCTTGCTCTGC-3’ (producing a 192 bp PCR product) (30). The 
Rotor-Gene 6000 thermal cycler (Corbett Life Sciences, Qiagene) was used with the following 
profile: 95˚C 2 minutes, followed by 40 cycles of 95 ˚C 10 seconds, 52 ˚C 10 seconds and 72 ˚C for 
20 seconds. This was followed by a standard melt analysis to assess specificity of the amplified 
product. Two technical replicates (separate qPCR reactions on the same DNA) were performed for 
each sample (with a third been done where necessary) and DNA extracted from flies without 
Wolbachia was used as a negative control. Mean normalized WSP:RpL32 DNA ratios were 
calculated using qGENE software (52), and statistical analysis included a two-tailed Student’s t-test 
to compare differences of the means. 
Survival bioassay 
Virus for larval and adult feeding assays was prepared by injecting flies with either 5000 infectious 
units (IU) of DCV, or an equivalent volume of phosphate buffered saline (PBS) which acted as a 
control. Live flies were collected at 4 days post-injection and stored at -20 ˚C until further use. 
Thirty PBS or DCV injected flies were pooled, homogenized in 300 µl of PBS, and the supernatant 
filter sterilized using the Millex GV 22 µm filter (Merck Millipore). Homogenates prepared in this 
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way were used for both adult and larval bioassays. The titre of DCV-injected fly homogenates were 
measured on four occasions and ranged between 4.4 x 1010 and 2 x 1011 IU/ml.  
 
For adult infections a modified version of a previously described method was used (37). A 
250 µl of a mix containing 75 % of the above described fly homogenate (DCV or PBS) and 25 % of 
dry yeast was applied to a 1.5 x 1.5 cm filter paper and placed in a vial containing ten 4 – 7 day old 
male flies. Flies were incubated with the media for 24 h at 25˚C with high humidity to prevent the 
food from drying out. Following this period, the flies were transferred to standard cornmeal media 
and daily mortality was scored for 15 days. Three replicates on independent cohorts were performed 
for each treatment. 
 
Larval infections were performed by spreading DCV or mock infected fly homogenates onto 
petri dishes containing 10 ml of standard cornmeal media (36). 100 eggs were collected for each 
treatment on a wet piece of sterile filter paper, and transferred onto petri dishes containing 
homogenates from either PBS or DCV injected flies. Larvae were maintained on the treatment 
media until adult emergence, when they were counted 3 days post-emergence. Egg to adult survival 
was determined as a proportion of adults post-emergence compared to the initial number of eggs at 
the start of the treatment, and each survival bioassay was replicated 3 times on independent cohorts 
of insects. 
Statistical analysis of the survival bioassay 
We used Generalized Linear Mixed Effects Regression (GLMER) models based on a binomial 
distribution to examine the effect of feeding treatment and co-infection on the mortality of five D. 
melanogaster and simulans larvae using the lme4 R package in R 2.15.3 (53) (R Foundation for 
Statistical Computing, Vienna, Austria). The mortality response, as the binomial count of flies that 
survived or died for each line, was determined by fitting the feeding treatment (PBS, DCV) and co-
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infection treatment (-wol, Wolbachia strain), as well as the interaction between the two factors. The 
interaction term compares across the mortality values of each of the feeding treatments across the 
absence (-wol) or presence (+Wolbachia strain) of Wolbachia. Each model included experimental 
replicate as a random factor, included as replicate variance component in each model. For adult 
survival bioassays, the survival curves were compared using Kaplan-Meier analysis and log-rank 
statistics using GraphPad Prism. 
 
Results 
Wolbachia protection in adult flies following oral challenge with DCV 
Initially, we tested the protective effects of the Wolbachia strain wAu in CO fly background (CO-
wAu) due to a strong antiviral protection observed previously following a systemic DCV infection 
(29). Wolbachia-free CO flies challenged with DCV by oral infection showed 40 % mortality 
within 15 days post-feeding. In contrast, CO-wAu flies showed a significant reduction in mortality 
during the same time period to 7% (Figure 1A, Kaplan-Meyer analysis, p < 0.05). We investigated 
an additional three Drosophila-Wolbachia associations DSR-wRi, w1118-wMel, w1118-wMelPop, all 
of which have previously been shown to confer protection against DCV-induced mortality in adult 
flies following a systemic infection (3, 29, 49), and the results indicate that all three Drosophila-
Wolbachia associations conferred protection against DCV-induced mortality following the oral 
route of infection (Figure 1B, D, E, Kaplan-Meyer analysis, p < 0.05). Because not all Drosophila-
Wolbachia associations protect against systemic viral infections, we tested a non-protective 
association N7NO-wNo to see whether protection would occur following oral virus challenge (29). 
Feeding the non-protective N7NO-wNo flies with DCV lead to a non-significant difference in viral-
induced mortality compared to Wolbachia-free flies (Figure 1C, Kaplan-Meyer analysis, p > 0.05). 
Taken together these results indicate Wolbachia-mediated protection against virus-induced 
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mortality in adults infected through the oral route was consistent with what was previously reported 
following injection of virus. 
 
Figure 1. Survival of adult flies following oral challenge with DCV.  Each fly line contained a 
different Wolbachia strain (+wol) or was tetracycline treated to remove Wolbachia (-wol). Adult 
flies were exposed to either homogenates from DCV or mock infected (PBS) flies for 24 hours 
before being transferred to vials containing standard cornmeal media. Survival of flies is shown 
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from 3 biological replicates of 10 flies or one replicate of 10 flies for PBS controls. Differences in 
survival were determined statistically using the log rank test on Kaplan-Meier curves. 
Wolbachia protection in larvae following oral challenge with DCV 
To determine whether the presence of Wolbachia protects larvae from virus-induced mortality, we 
orally challenged CO-wAu larvae with DCV. We found that in Wolbachia-free flies, larval to adult 
mortality increased from about 37% in mock-infected flies, to about 46% in DCV-infected flies and 
that the presence of Wolbachia had no significant effect on DCV-induced mortality (Figure 2A and 
Table 1). This suggests that the Wolbachia strain wAu may not protect its host against DCV-
induced mortality following this route of infection at the larval developmental stages. 
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Figure 2. The impact of Wolbachia on virus-induced mortality in DCV infected Drosophila 
larvae.  Each fly line (shown in title of each graph) contained a different Wolbachia strain or was 
tetracycline treated to remove Wolbachia (-wol) as indicated on the x-axis. Larvae were exposed to 
either homogenates from DCV or mock infected (PBS) flies. Graphs display means and standard 
errors from three replicates of 100 individuals per line. * indicates a significant interaction (p < 
0.05) between the feeding treatment and presence or absence of Wolbachia on mortality. 
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As no protection was observed in CO-wAu larvae, we then investigated whether the lack of 
protection was specific to this Drosophila-Wolbachia association. We investigated other protective 
Drosophila-Wolbachia associations DSR-wRi and w1118-wMel, and one non-protective association 
N7NO-wNo. None of these associations showed significant differences in DCV-induced mortality 
between larvae with and without Wolbachia (Figure 2B-D and Table 1), suggesting that the lack of 
Wolbachia-mediated protection at the larval stages is not confined to CO-wAu flies. 
 
The Wolbachia strain wMelPop has a strong protective effect in both adult flies and 
mosquitoes, so we investigated whether w1118-wMelPop larvae exhibit a protective phenotype. In 
this Drosophila-Wolbachia association there was a statistically significant difference in DCV-
induced mortality between flies with and without Wolbachia (25% and 37% mortality, respectively) 
(Figure 2E and Table 1). Unlike the other Drosophila-Wolbachia associations, wMelPop provided 
complete protection against DCV induced mortality (Figure 2E). Because the ability to confer 
antiviral effects is strongly associated with Wolbachia density in adult flies and mosquitoes, and 
because wMelPop is known to be an over-replicative strain, we investigated whether the observed 
differences in Wolbachia protection were associated with differences in Wolbachia densities.  
Wolbachia density  
Wolbachia densities have previously been determined for different Drosophila-Wolbachia 
associations in adults but not in larvae. Using quantitative PCR (qPCR) we determined Wolbachia 
densities at both larval and adult stages for all five Drosophila-Wolbachia associations used in this 
study (Figure 3). In adults, the densities of the protective Wolbachia strains wAu, wRi, wMel and 
wMelPop are significantly higher compared to the non-protective wNo strain, providing an 
association between Wolbachia density and protection. In contrast, Wolbachia strains wAu, wRi and 
wMel show lower abundance at the larval compared to adult stages (two-tailed Student’s t-test, p < 
0.05, Figure 3A, B), while the Wolbachia strain wMelPop shows high densities at both larval and 
 64 
adult stages (Figure 3A). Wolbachia density in the non-protective N7NO-wNo larvae remained at 
lower densities compared to both wRi and wAu at both developmental stages (Figure 3B), 
consistent with lack of protection.   
 
Figure 3. The density of five different Wolbachia strains during larval and adult stages of 
development. (A) Relative abundance of the Wolbachia surface protein (WSP) gene in D. 
melanogaster using RpL32 as a reference gene. (B) Relative abundance of the WSP gene in D. 
simulans using Act5C as a reference gene. 
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Discussion 
The importance the route of pathogen entry has on the outcome of infection has been well-
documented following bacterial infections in Drosophila. Injecting bacteria into the hemocoel 
induces a systemic immune response (54-57), while oral infections often lead to a localized immune 
induction in the gut, often making them less pathogenic (58-60). A recent paper showed the 
involvement of the Toll immune pathway in mediating resistance to oral infections with DCV, 
Flock House virus, Cricket paralysis virus and Nora virus, however showed no involvement of the 
pathway following a systemic infection (37), indicating that the route of viral entry can have an 
affect on the host’s response to viral infection. 
 
 We used a natural route of DCV infection through oral feeding, to investigate the effect of 
Wolbachia on protection against viral-induced mortality to investigate whether Wolbachia-mediated 
protection is confined to systemic viral infections in Drosophila. By examining Wolbachia-
mediated protection in adult flies across four Drosophila-Wolbachia associations that have 
previously been shown to be protective following systemic infection, we show that oral DCV 
infections lead to a reduction in viral-induced mortality in adult flies with Wolbachia compared to 
Wolbachia-free flies (Figure 1). These findings are consistent with a recently published report (37) 
and support the idea that Wolbachia-mediated protection extends beyond systemic viral infections 
and could be used in future experiments to better understand the effects of Wolbachia on viral 
dynamics in natural insect populations.  
 
While in adults, Wolbachia-mediated reduction in viral-induced mortality is comparable 
between systemically and or orally infected flies, the same is not always true in larvae. Out of the 
four Drosophila-Wolbachia associations that show protection following DCV infection in adults, 
only the w1118-wMelPop flies showed protection against DCV-induced mortality during the larval 
stages (Figure 2E). These results suggest that Wolbachia-mediated protection may vary between 
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different life stages of the same Drosophila-Wolbachia associations, although it is possible that the 
amount of virus ingested by larvae and adults is different. Since Wolbachia density has previously 
been shown to be important for mediating antiviral effects, we measured Wolbachia density in 
adults and found that there was congruence between Wolbachia density and protection against 
DCV-induced mortality following the oral route of infection. Similarly to adults, Wolbachia-
protection in larvae was associated with Wolbachia density, however interestingly high Wolbachia 
density was only observed in w1118-wMelPop larvae, which was also the only association to show 
protection against DCV-induced mortality at the larval stages. The wMelPop strain causes a life-
shortening phenotype and is present in relatively high densities in both mosquitoes and Drosophila 
(7, 61-63). The relatively high density and the life-shortening effects of the wMelPop strain have 
been reported to be due to the high copy number of 8 Wolbachia genes referred as the Octomom 
region (31, 62). It remains to be seen whether other strains will be protective in larvae and what 
controls the differences in density between larvae and adults. The finding that Wolbachia-protection 
correlates with Wolbachia density is consistent with previous findings in adult flies following a 
systemic infection (29-32).  Gradually reducing Wolbachia density in both Drosophila adults and 
mosquito cell culture using tetracycline leads to a dose-dependent loss of antiviral protection (12, 
30).  
 
Wolbachia-mediated antiviral protection is not limited to Drosophila, and since Wolbachia 
infects up to 40 % of all arthropod species (35) it may be important to consider the impact of life-
stage susceptibility on arthropod population dynamics and viral transmission. Similarly to 
Drosophila, mosquitoes also undergo metamorphosis, a change that can result in life-stage 
dependent differences in viral susceptibility. Mosquitoes are known to form natural associations 
with Wolbachia, however it is the artificial Wolbachia transinfections that have shown promise as a 
tool for limiting spread of human pathogenic viruses (5, 6). Commonly, there is a focus on 
transmission of arboviruses that occurs between the mosquitoes and human hosts. While this 
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horizontal transmission is responsible for the major health concerns in humans, vertical 
transmission of arboviruses within mosquito populations can affect the maintenance of the virus 
within the population (64, 65). Viruses such as dengue and chikungunya can be vertically 
transmitted from an infected adult female to its offspring. Dengue virus can spread vertically in both 
natural (66-69) and laboratory conditions (70-72). Furthermore transovarially infected female 
mosquitoes can transmit dengue virus orally (73). chikungunya is also capable of vertical 
transmission in laboratory conditions, which would suggest that a similar transmission is possible in 
nature (64).  
 
Various models have been applied to try to understand the impact of Wolbachia on the 
transmission of dengue in its mosquito host (74-76). These models do not consider the effects of 
vertical transmission on the maintenance of dengue within a population, which has been suggested 
to be an important factor affecting the ability of the virus to persist within the population in rural 
areas with low population densities (65). Furthermore vertical transmission could allow the survival 
of arboviruses during adverse climatic conditions, and has been suggested to be an important 
mechanism of maintenance of the virus during inter-epidemic periods (64). Given the importance of 
vertical transmission on virus dynamics, and the possible life-stage-dependent variations in 
Wolbachia-mediated protection, it is important to consider the impact of Wolbachia antiviral 
protection, or the lack of thereof on the maintenance of the virus within the population. 
Understanding the impact of Wolbachia antiviral protection at different life stages is likely to be an 
important consideration when designing programs to minimize the spread of insect borne viruses. 
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Table 
Table 1. Analysis of mortality in response to DCV feeding in Drosophila larvae either with or 
without Wolbachia. Generalised linear mixed effects regression (GLMER) analysis of five 
Drosophila lines mortality (%) in response to a feeding treatment of Phosphate-Buffered Saline 
(PBS) or Drosophila C Virus (DCV). Each line was either co-infected with a Wolbachia strain 
(wAu, wRi, wNo, wMelPop, wMel) or Wolbachia-free (-wol). 
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 Estimate Std. Err. z-value p-value 
Line: CO     
Intercept -0.147 0.116 -1.269 0.204 
Feeding treatment -0.357 0.166 -2.147 <0.05 
-wol: wAu -0.081 0.164 -0.492 0.623 
Treatment × -wol: wAu -0.081 0.235 0.343 0.731 
Replicate variance component 0 0   
Line: DSR     
Intercept -0.134 0.116 -1.154 0.249 
Feeding treatment -0.53 0.168 -3.152 <0.01 
-wol: wRi 0.067 0.164 0.409 0.683 
Treatment × -wol: wRi -0.052 0.237 -0.219 0.827 
Replicate variance component 2.4×10-11 4.8×10-6   
Line: N7NO     
Intercept -0.619 0.121 -5.114 <0.0001 
Feeding treatment -0.41 0.178 -2.296 <0.05 
-wol: wNo 0.058 0.17 0.341 0.733 
Treatment × -wol: wNo -0.182 0.254 -0.717 0.474 
Replicate variance component 9.7×10-15 9.8×10-8   
Line: w1118     
Intercept -0.518 0.119 -4.339 <0.0001 
Feeding treatment -0.545 0.178 -3.062 <0.01 
-wol: wMelPop -0.563 0.179 -3.154 <0.01 
Treatment × -wol: wMelPop 0.649 0.257 2.522 <0.05 
Replicate variance component 5.9×10-12 2.4×10-6   
Line: w1118     
Intercept -0.504 0.119 -4.228 <0.0001 
Feeding treatment -0.631 0.18 -3.51 <0.001 
-wol: wMel -0.101 0.17 -0.594 0.553 
Treatment × -wol: wMel 0.137 0.254 0.537 0.591 
Replicate variance component 0 0   
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Abstract 
Innate immunity plays a crucial role in protection against pathogen invasion in arthropods as they 
lack adaptive immunity. Apoptosis, a form of programmed cell death, has long been recognized for 
its importance in tissue reorganization and development, and has recently been accepted as a 
component contributing to innate immunity. Early induction of apoptosis in Drosophila leads to a 
decrease in accumulation of Flock House virus (FHV) following haemocoelic injection. Because 
the route of pathogen infection can lead to differential immune regulation and outcome of infection, 
we investigated whether the antiviral impact of apoptosis is route-of-infection-dependent. Here we 
show that apoptosis leads to different effects on viral accumulation (resistance) and host survival 
(tolerance) depending on whether apoptosis is experimentally inhibited or enhanced. We analyzed 
the response to virus infection of fly mutants with the transcriptional factor dP53 deleted, which 
would be expected to inhibit apoptosis, and gain-of-function mutants that over-express the pro-
apoptotic gene reaper, which would be expected to enhance apoptosis. Enhancing or inhibiting 
apoptosis had no effect on the number of flies that succumb to oral FHV infection (30 % in all 
cases). Inhibition of apoptosis had no effect on FHV accumulation following the oral route of 
infection, however mortality occurred earlier in dP53 mutants compared to wild type. Conversely, 
increasing the expression of the pro-apoptotic gene reaper in over-expression mutants led to a 
reduction in FHV accumulation, however did not affect host survival following the oral route of 
FHV infection. Taken together we propose that apoptosis is likely not involved in the control of 
primary FHV infection (viral entry and establishment), and that the antiviral effects of apoptosis is 
tissue-specific.  
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Introduction  
Viruses carry a heavy burden on the infected host, in part because they use the host’s intracellular 
components for their replication. During evolution, organisms have evolved ways of evading 
pathogen infection through the establishment of the immune system. While mammals have evolved 
two types of immunity, the innate and adaptive, insects like Drosophila lack the adaptive immune 
system and use the innate immune system as a mechanism of controlling viral infection (reviewed 
in 1).  
 
Apoptosis has long been suggested to be part of the innate immune system in Drosophila, 
however this is a concept that is only recently becoming accepted. Apoptosis is a controlled mode 
of cell death, during which cells undergo morphological changes that culminate in cell death and 
removal (2, 3). Early induction of apoptosis in several organisms can limit viral accumulation 
through the destruction of the hosts cell machinery necessary for viral replication (4-6). 
In Drosophila, apoptosis is suppressed by a family of functionally and structurally related proteins 
called inhibitors of apoptosis (IAPs), with DIAP1 serving as the principal IAP (7). DIAP1 acts as an 
inhibitor of caspases, that is responsible for a deliberate degradation of the cell (8-10). Following 
apoptotic stimuli, induction of apoptosis occurs through the transcriptional activation of four genes: 
reaper (rpr), hid, grim and sickle (RHG genes), which play an essential role in developmentally 
regulated cell death (11), and are involved in protection against viral invasion (12). Induction of 
RHG genes often occurs through the activation of the transcriptional factor dP53 (13). 
Transcriptional activation of the RHG genes leads to a depletion of DIAP1 and activation of the 
most apical caspase Dronc (14). Once activated, Dronc cleaves and activates executioner caspases, 
leading to cell death (8-10) (Figure 1).  
 
 
Figure 1. Regulation of apoptosis in Drosophila. The transcriptional factor dP53 activates the 
expression of reaper, hid, grim and sickle genes, which function to promote DIAP1 degradation. 
Degradation of DIAP1 releases the brakes on apoptosis leading to activation of caspases resulting in 
cell death.  
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Until recently, the effect of apoptosis as an antiviral mechanism in Drosophila was under 
question, as infection of cultured Drosophila cells with the baculovirus Autographa californica 
multicapsid nucleopolyhedrovirus (AcMNPV) or Flock House virus (FHV) lead to the induction of 
apoptosis relatively late in the infection cycle (24 h), and blocking apoptosis had no effect on FHV 
accumulation (15, 16). Unlike cell culture studies, injecting adult Drosophila flies with either FHV 
or Culex nigripalpus Nucleopolyhedrovirus (CuniNPV) leads to a quick induction of apoptosis 
through the up-regulation of the pro-apoptotic rpr and hid genes at 1 hour post-injection. The up-
regulation of rpr and hid is followed by the induction of caspases and apoptosis within 2.5 hours 
post infection (12). Expression of rpr and hid require the function of dP53 and the irradiation-
responsive enhancer region (IRER), as dP53 and IRER loss-of-function mutant flies lose the ability 
to induce apoptosis and show higher FHV and CuniNPV titers. Suppressing apoptosis by knocking-
down the apical caspase Dronc specifically in the fat body results in an increase in AcMNPV and 
FHV viral titers, suggesting the importance of apoptosis as an antiviral pathway in Drosophila (12).  
While studies performed in adult flies have shown that systemic viral infections can induce 
the apoptotic pathway, it is still to be determined whether apoptosis is involved in antiviral 
protection following the oral route of infection. The importance of the route of pathogen entry on 
the outcome of infection has been well documented following bacterial infections in Drosophila. 
Injecting bacteria into the hemocoel of Drosophila induces a systemic immune response (17-20), 
while oral infections often lead to a localized immune induction in the gut often limiting the 
pathogenic effects of the bacterial infection (21-23). There is some evidence that route of infection 
also leads to differential immune regulation following viral infections, as infections with Drosophila 
C virus (DCV), FHV, Cricket paralysis virus (CrPV) and Nora virus lead to the induction of the 
Toll pathway following oral infection but not following a systemic infection (24). Furthermore 
knocking-down genes essential in Toll pathway regulation has no effect on fly survival or viral 
accumulation following systemic infection with DCV, FHV, CrPV and Nora viruses, while oral 
infection with the same viruses results in an increase in the number of infected flies and an increase 
in viral accumulation (24). Because Drosophila is thought to acquire most viruses through ingestion 
of contaminated media (25), understanding the role of immune pathway regulation in natural 
Drosophila populations will require a better understanding of immune regulation following oral 
viral infections.  
  
To investigate whether the involvement of apoptosis in antiviral protection is dependent on 
the route of infection, we analyzed the effect of apoptosis on FHV accumulation and host survival 
following systemic and oral infection.  
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Materials and Methods 
Virus  
Plaque purified FHV (26, 27) was propagated and purified from Schneider’s Drosophila Line 2 
cells (28). The virus used for injection experiments was sucrose gradient purified as previously 
described (26), while the virus used for oral infection underwent only the sucrose cushion 
purification step.  
 
Fly lines 
Flies were reared on standard cornmeal media, at a constant temperature of 25°C with a 12-hour 
light/dark cycle unless otherwise stated. Drosophila w1118 strain was used as a standard wild type 
strain (29). The P53 -/- fly line (P53[5A-1-4]), which is homozygous for a 3.3k deletion in the P53 
gene was obtained from Bloomington (Indiana University, Bloomington, IN, USA; Stock no. 6815). 
Over-expression of the rpr and Dronc genes was achieved using the Gal4/UAS system. The driver 
line (w[*] P{w[+mC]=GAL4-Hsp70.PB}) contains a Gal4 gene under the control of a heat-sensitive 
Hsp70 promoter and was obtained from Bloomington (Stock no. 1799). Induction of rpr and Dronc 
was achieved using the responder lines (CyO{UAS-rpr.C}3) and w*;P{UAS-Dronc.FLAG}2. The 
UAS-Dronc responder line was kindly provided by Dr. Loretta Dorstyn from the University of 
South Australia, while the UAS-rpr line was provided by Dr. Gary Hime at the University of 
Melbourne. Crossing the Gal4 driver line with UAS responder lines leads to heterozygous F1 
progeny containing both Gal4 and UAS. Transferring Gal4/UAS flies to 30°C leads to the 
activation of the Gal4 transcriptional factor that contains a DNA-binding domain capable of binding 
to upstream activation sequence (UAS) allowing transcription of the target gene to occur. Rearing 
the flies at 18°C suppresses the activation of Gal4, therefore suppressing the transcription of the 
target gene. Following a cross between the driver and responder lines, the flies were reared at 18°C, 
and 2-5 day old male Gal4/UAS flies were heat-shocked at 30°C for 2 days and subsequently 
transferred to 25°C for the remainder of the experiment. All flies used in the experiments were 
Wolbachia-free. 
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Western blotting  
Western blotting was performed based on a previously described protocol with slight modifications 
(30). Briefly, 15 flies were ground in PBS and the homogenates electrophoresed  through a 10% 
SDS-PAGE gel. Semi-dry transfer (Biorad) was used to transfer the proteins to polyvinylidene 
difluoride membranes for 60 minutes at 20V. The membrane was blocked for 1 h (5 % skim milk in 
PBS containing 0.05 % Tween 20), and incubated with the anti-Dronc antibody at a dilution of 
1:500 for 3 h at room temperature, followed by the anti-rabbit (Abcam) antibody for 1 h. The signal 
was detected by developing the blot with NBT/BCIP substrates (Life technologies) for 10 minutes 
at room temperature. This was followed by probing the membrane with the AP-conjugated anti-
Tubulin (Abcam) antibody at a dilution of 1:100 for 1 h followed by the anti-mouse (Abcam) 
antibody for 1 h. The blot was developed with NBT/BCIP for 10 minutes.  
 
The primary polyclonal anti-Tubulin antibody and the secondary anti-mouse and anti-rabbit 
antibodies were ordered from Abcam (USA), while the polyclonal anti-Dronc antibody was a kind 
gift from Dr. Loretta Dorstyn from the University of South Australia. 
 
RNA extraction, cDNA synthesis and qPCR  
Insect samples were frozen and homogenized in Ribozol TM (Amresco) with two 3 mm glass beads 
using TissueLyser II (Qiagen) for 90 seconds at 30 Hz. The total RNA was precipitated from 
Ribozol as per manufacturers instructions and the samples were treated with DNase (Promega) for 
30 minutes at 37°C. One microgram of total RNA was reverse transcribed using either FHV-R or 
rpL32-R primers (Table 1). The primers were used at a final concentration of 100 nM, and annealed 
to RNA by at heating at 65°C for 5 min before being set on ice for 1 minute. cDNA was synthesized 
using SuperScript III reverse transcriptase (Invitrogen) at 55°C for 60 min, and then heat 
inactivated at 95°C for 15 min. For quantitative PCR analysis Platinum SYBR® Green qPCR 
SuperMix-UDG (Invitrogen) was used as per manufacturer’s instruction using FHV-F/ FHV-R, 
Reaper-F / Reaper-R or rpL32-F / rpL32-R primer pairs (Table 1). The Rotor-Gene 6000 thermal 
cycler (Corbett Life Sciences, Qiagene) was used with the following profile: 95˚C 2 minutes, 
followed by 40 cycles of 95˚C 10 seconds, 60˚C 10 seconds and 72˚C for 20 seconds. This was 
followed by a standard melt analysis to confirm that only the expected product had been amplified. 
Two technical replicates were performed for each sample (with a third done where necessary). RT-
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qPCR data were analysed using qGENE software (31), and statistical analysis included a two-tailed 
Student’s t-test to compare differences of the means. 
 
Oral infection 
Since natural infections are likely to occur by ingesting contaminated food, adult flies were infected 
by feeding on contaminated media. Oral infection was performed in a plastic vial containing 1.5 x 
1.5 cm of sterile filter paper contaminated with 200 µl of a mix containing 75 % of virus extract + 
PBS and 25 % of dried yeast, at a final virus concentration of 1011 IU/ml. For the control flies, the 
virus extract was replaced by PBS. Each vial contained 15 flies exposed to virus for a period of 24 
hours. Following the infection period, the flies were set on standard cornmeal media and survival 
was measured daily. The day on which the flies were set to feed on the viral extract was considered 
to be day 0. Each experiment was performed 3 times using independent cohorts of flies. 
 
Injection bioassay 
Drosophila were infected with FHV or mock infected with PBS through microinjection into the 
upper lateral part of the abdomen. Ten anaesthetized 4-7 day old male flies were injected with 250 
infectious units (IU) of FHV and maintained on a constant temperature of 25°C and daily mortality 
was scored. Each experiment was replicated 3 times using independent cohorts of flies. Survival 
curves were compared using Cox Regression analysis (GraphPad Prism). 
 
Statistical analysis 
Relative abundance of genes was calculated in qGENE and statistical analysis included the Mann-
Whitney t-test to compare differences of the means. Survival curves were compared using Cox 
Regression analysis (GraphPad Prism). To evaluate whether time-to-death of orally infected flies 
differed between treatments, Cox Regression analysis was computed on the proportion of flies that 
succumbed to the infection.  
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Results 
Confirmation of fly mutants 
To investigate the role of apoptosis in protection against FHV infection following viral ingestion, 
we used mutant Drosophila flies. Flies containing a deletion in dP53 were confirmed to be 
homozygous for the deletion using PCR across the deleted region (data not shown). To generate 
flies with altered levels of apoptosis in additional apoptosis genes, we used the inducible Gal4/UAS 
system. The F1 progeny containing both Gal4 and UAS-rpr was used to study the effects of rpr 
over-expression. Because the rpr gene is transcriptionally regulated in Drosophila (32-34), RT-
qPCR analysis was performed to confirm that rpr induction was successful. Expression analysis of 
the Gal4-Hsp70/UAS-rpr flies (referred from now on simply as rpr-UP) showed a 4-fold increase in 
rpr expression at 48 h post heat-shock compared to the same fly line kept at 18°C (Figure 2, t-test, p 
< 0.05), while the WT flies showed no difference in gene regulation at either temperatures (Figure 
2,t-test, p > 0.05).  
 
 
 
 
Figure 2. Abundance of reaper mRNA in WT and mutant flies. Relative abundance of the rpr 
gene as measured by RT-qPCR in wild type w1118 and rpr-UP flies at 18°C and 30°C. Relative 
expression of rpr was calculated using the host Rpl32 mRNA as a reference. Each bar represents 
three biological replicates of five individual flies along with the mean ± SD. * represents statistical 
significant difference in rpr regulation in mutant flies reared at 30°C compared to the same fly line 
reared at 18°C (p < 0.0001). 
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To induce expression of the caspase Dronc, the Gal4-Hsp70 driver line was crossed to the 
UAS-Dronc responder line (referred from now on simply as Dronc-UP). Because Dronc is regulated 
post-transcriptionally (35), Western blot analysis was performed to measure relative protein 
expression. Western blot analysis was performed on pools of 15 WT and mutant flies before and 
after heat shock. In WT flies the Dronc protein was not detected at either 18°C or 30°C, while 
Dronc-UP flies showed low protein abundance at 18°C, and an increase in abundance at 30°C 
(Figure 3), suggesting that the protein was successfully induced.  
 
 
 
 
Figure 3. Western blot analysis of Dronc protein expression. Analysis of WT and Dronc-UP 
mutant flies before heat shock (18°C) and 48 h after heat shock (30°C). The blot shows the 
abundance of the target protein Dronc (55kDA) and reference protein Tubulin (50 kDa).  
 
Systemic FHV infection 
To determine whether the effects of apoptosis are dependent on the route of virus infection, we first 
investigated how knocking out the pro-apoptotic gene dP53 and increasing the expression of the 
pro-apoptotic genes rpr and Dronc would affect FHV accumulation and host survival following 
systemic FHV infection. Compared to WT flies, P53 -/- flies injected with FHV had an 
approximately 7-fold increase in viral accumulation at 24 h post-injection (Figure 4A). Survival 
bioassays of systemically FHV-infected flies showed that FHV injection caused 100 % mortality of 
WT flies by day 6, while injecting the same amount of FHV into P53 -/- flies lead to a 100 % 
mortality by day 5 post-injection (Figure 4B, p < 0.05, Table 2).   
 86 
 
 
 
 
 
Figure 4. Impact of apoptosis on FHV infection by injection. (A, C, E) Relative FHV abundance 
in adult flies 24 h post FHV injection. Black dots represent FHV abundance in WT flies, while red 
squares represent FHV abundance in mutant flies. The abundance of FHV RNA1 was calculated 
using the host Rpl32 mRNA as a normaliser. Each data point represents a single fly, and the graph 
is fitted with a mean ± SD. Unpaired t-test was used to compare the differences of the means and 
showed that in all three cases the difference in FHV abundance between WT and mutant flies is 
significantly different (p < 0.01). (B, D, F) Analysis of mortality of flies injected with FHV. Grey 
dashed lines represent mock-injected flies (PBS), black lines represent FHV-injected WT flies, 
while red lines represent FHV-injected mutant flies. Survival of flies is shown from 3 replicates of 
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10 flies or one replicate of 10 flies for PBS controls. Cox Regression analysis was performed to 
determine whether differences in mortality between WT and mutant flies were significant. The data 
is representative of 3 biological replicates and the results are shown as means ± SD. 
 
Injecting rpr-UP flies with FHV led to an approximately 14-fold decrease in FHV 
accumulation at 24 h post-injection compared to WT flies (Figure 4C, t-test, p < 0.05). Survival 
bioassay analysis of systemically infected rpr-UP flies showed that the flies succumbed to the 
infection significantly later compared to WT flies; FHV injection caused 100 % mortality of WT 
flies by day 7, while injecting the same amount of FHV into rpr-UP flies lead to a 100 % mortality 
by day 15 post-injection (Figure 4D, p < 0.05, Table 2).   
 
Injecting Dronc-UP flies with FHV lead to an approximately 11-fold decrease in FHV 
accumulation at 24 h post-injection compared to WT flies (Figure 4E, t-test, p < 0.05). Scoring 
daily mortality of systemically infected Dronc-UP flies showed that the flies succumbed to the 
infection significantly later compared to WT flies, as FHV injection caused 100 % mortality of WT 
flies by day 7, while injecting the same amount of FHV into Dronc-UP flies lead to a 100 % 
mortality by day 13 post-injection (Figure 4F, p < 0.05, Table 2).   
 
Oral FHV infection 
To compare the effects of apoptosis between systemically and orally infected flies, we orally 
infected P53 -/-, rpr-UP and Dronc-UP flies with FHV and measured the effect it has on FHV 
accumulation and host survival following the oral route of FHV infection. Oral infection of P53 -/- 
flies lead to no difference in FHV accumulation at 2 or 5 days post-feeding compared to WT flies 
(Figure 5A, C). Interestingly, while no difference in viral accumulation was observed, P53 -/- flies 
succumbed to the infection significantly earlier compared to WT flies (Figure 5E, p < 0.05, Table 
2). A dichotomy in FHV abundance data was observed where at 5 days post-feeding FHV is either 
found at very low or very high abundance. FHV abundance at 5 days post-feeding (Figure 5A) 
shows that 70 % of WT and P53 -/- flies contain low levels of FHV while 30 % show at least a 300-
fold higher abundance of virus. Comparison between 2 and 5 days post-feeding (Figure 5A, C) 
shows that in 70% of flies, FHV abundance did not change between 2 and 5 days post-feeding, 
implying that no FHV replication had occurred in 70% of flies between 2 and 5 days post feeding. 
This conclusion is consistent with the survival data, which shows that only 30 % of flies succumbed 
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to the infection (Figure 5E). Furthermore, no difference in the number of flies succumbing to oral 
FHV infection was observed between P53 -/- and WT flies. 
 
 
 
 
Figure 5. Impact of apoptosis on FHV infection by oral feeding. (A, B) Relative FHV 
abundance in WT and P53 -/- and rpr-UP flies respectively at 2 days post FHV oral feeding. (C, D) 
Relative FHV abundance in WT and P53 -/- and rpr-UP flies respectively at 5 days post FHV oral 
feeding.  Black dots represent FHV abundance in WT flies, while red squares represent FHV 
abundance in mutant flies. Relative abundance of FHV was calculated using the host Rpl32 mRNA 
as a normalizer.  Each data point represents an individual fly, and the graph is fitted with a mean ± 
SD. (E, F) Analysis of mortality of P53 -/- and rpr-UP flies respectively orally infected with FHV. 
Grey dashed lines represent mock-infected flies (PBS), black lines represent wild-type FHV fed 
flies, while red lines represent mutant FHV fed flies. Survival of flies is shown from 3 replicates of 
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10 flies or one replicate of 10 flies for PBS controls. Cox Regression analysis was performed to 
determine whether differences in mortality between WT and mutant flies were significant. Results 
are shown as means ± SD.  
 
Orally infecting rpr-UP flies lead to no difference in FHV accumulation at 2 days post oral feeding 
compared to WT flies (Figure 5B, t-test, p > 0.05), however at 5 days it showed significantly lower 
FHV abundance compared to WT flies (Figure 5D, t-test, p > 0.05). Interestingly, while a difference 
in viral accumulation was observed at 5 days post oral feeding, no difference in mortality was 
observed between rpr-UP and WT flies (Figure 5F, p > 0.05, Table 2). No difference in the total 
number of flies succumbing to oral FHV infection was observed between rpr-UP and WT flies. 
   
Discussion 
P53-mediated protection 
While apoptosis has recently been shown to control virus abundance following systemic FHV 
infection, the impact of apoptosis on virus-induced mortality and the involvement of apoptosis in 
antiviral protection following the oral route of infection had not been documented. To compare the 
effects of apoptosis in controlling virus-induced death following systemic and oral infections, we 
first determined the importance of the pro-apoptotic gene dP53 in protecting flies from virus-
induced mortality and interfering with virus accumulation. Interestingly, the effect of knocking-out 
dP53 on virus accumulation was route-of-infection dependent, as systemic infection of P53 -/- flies 
led to an increase in FHV accumulation (Figure 4A), while no such effect was observed in orally 
infected flies (Figure 5A, C). The observed increase in FHV accumulation following systemic 
infection of P53 -/- flies is consistent with a previous report (12). While the effect of dP53 on 
control of pathogen accumulation (resistance) was dependent on the route of infection, the ability of 
the host to endure infection (tolerance) was not route-of-infection-dependent, as host’s tolerance to 
virus infection was negatively affected in P53 -/- mutants regardless of the route of virus infection 
(Figure 4B, 5E). These results suggest that inhibition of apoptosis through dP53-mediated knock-
out can affect viral resistance in a route-of-infection specific manner.  
Reaper-mediated protection 
Due to the differences between the two routes of infection following inhibition of apoptosis, we 
investigated the effect of increasing the expression of the pro-apoptotic gene rpr on viral resistance 
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and tolerance. Up-regulation of rpr in rpr-UP flies showed a similar effect on viral resistance 
regardless of the route of infection, as in both cases up-regulation of rpr lead to a suppression of 
FHV accumulation (Figure 4C, 5D). While the effect of rpr on virus accumulation was comparable 
between the two routes of infection, the effect of rpr up-regulation on virus-induced mortality was 
route-of-infection dependent. In systemically infected rpr-UP flies a decrease in FHV accumulation 
was associated with a delay in mortality (Figure 4C, D), while a decrease in FHV accumulation in 
orally infected flies did not show the same effect, as both the WT and rpr-UP flies showed similar 
rates of mortality (Figure 5D, F). These results indicate that following the oral route of infection 
enhancement of apoptosis has an effect on viral resistance, but not tolerance. Because inhibiting or 
enhancing apoptosis lead to variable effects on resistance and tolerance, it would be interesting to 
confirm these results by orally infecting Dronc-UP flies with FHV and determine the effect on 
resistance and tolerance. Unfortunately, Dronc over-expression consistently lead to 70 – 80 % 
mortality within 24 hours post-feeding regardless of whether the flies were fed on FHV or mock-
infected media (Appendix 1).  
 
 The results show that the effect of apoptosis in systemically infected flies is consistent with 
the role of apoptosis as an antiviral mechanism, as induction of apoptosis leads to increased 
resistance and tolerance following FHV infection (Figure 4C-F), while inhibition of apoptosis leads 
to a decrease in resistance and tolerance (Figure 4A, B). The same is however not true for oral FHV 
infections, as inducing/inhibiting apoptosis leads to different effects on resistance/tolerance 
depending on the route of infection. A distinction is often not made between viral resistance and 
tolerance, as inhibiting viral replication is often associated with increased survival, however that is 
not always the case. An example of this is the antiviral protection conferred by the endosymbiotic 
bacteria Wolbachia in its Drosophila host. In most cases viral tolerance associated with Wolbachia-
mediated protection is correlated with a decrease in viral accumulation (resistance), however in 
some cases Wolbachia can affect tolerance without having an effect on resistance (36).  
 
Here we hypothesize that the differences in resistance and tolerance observed in this study 
are due to tissue-specific differences in sensitivity to apoptosis. Some support for this hypothesis 
comes from a comparison between the outcome of infection in Drosophila cell lines and adult flies. 
In Drosophila cell line DL-1 apoptosis occurs relatively late following FHV infection (36 hours 
post-infection) and blocking apoptosis has no effect on FHV infection or accumulation (15). 
Contrary to this observation, FHV injection in adult flies leads to a quick induction in apoptosis (2.5 
hours post-injection) and inhibiting apoptosis leads to an increase in viral titer (12). Adding to this, 
in the current study we show that inhibition/induction of apoptosis in adult flies is dependent on the 
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route of FHV infection. The apparent differences between the cell lines and adult flies suggest that 
apoptosis regulation may be tissue-specific, leading to differences in tissue sensitivity to virus 
infection. Because differences in tissue sensitivity may exist, host virus localization may be 
dependent on the route of pathogen entry, as the initial site of infection could affect viral 
competence and the outcome of infection. A study performed in the fall armyworm (Spodoptera 
frugiperda) larvae showed that AcMNPV lacking the apoptosis-inhibiting p35 gene and the 
neighbouring gene p94 leads to a route-of-infection-specific response to viral accumulation, leading 
to the hypothesis that the differences in infectivity are due to a tissue-specific response to p35 
and/or p94 (37).  
 
One finding that is of particular interest is that inhibiting or enhancing apoptosis has no 
effect on the number of flies becoming infected with the virus and succumbing to the infection, as 
both mutant and WT flies showed 30% mortality following oral feeding (Figure 5E, F). Comparing 
these findings with a recent paper showing that adult mortality following the oral route of FHV 
infection increased from ~20% in WT flies to ~60% in flies in which the Toll immune pathway has 
been compromised (24), it is clear that the Toll pathway is involved in determining whether or not a 
fly will become infected. In contrast, no such effect was observed in dP53 or rpr mutant flies. One 
interpretation of this is that apoptosis is not involved in the primary FHV infection, but that it may 
function as an antiviral pathway during secondary infection, however further experiments will be 
required to test this hypothesis. An alternative explanation is that both dP53 and rpr are not 
responsible for the activation of apoptosis in the gut, as regulation of apoptosis may be tissue-
specific. Understanding FHV progression following the oral route of infection would be invaluable 
in identifying the tissues that are important in primary FHV infection, however no such studies have 
been performed to date. Following systemic FHV infection, FHV has been observed in the 
cardiomyocytes (38), fat body and salivary glands (12), however FHV localization may not be 
confined to the above-mentioned tissues. 
 
Understanding the observed differences between resistance and tolerance will require 
elucidation of the mechanisms important in regulating viral resistance and tolerance. Currently, the 
molecular mechanisms underpinning viral tolerance in Drosophila are largely unexplored and 
poorly characterized. One indication of the mechanism underpinning tolerance during FHV 
infection comes from a study in Drosophila showing that injecting flies possessing mutations in the 
ATP-sensitive potassium channels with FHV leads to an increase in FHV viral load, increased 
tissue damage in the heart and earlier mortality compared to WT flies (38). While there is an 
indication that flies are succumbing to the infection due to the cytopathological effects of FHV in 
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the cardiomyocytes in the heart, it is not yet clear whether the heart is the only tissue involved in 
tolerance to virus infection.  
 
 Based on current knowledge we suggest that the differences in apoptosis-mediated 
protection may be due to tissue-specific differences in sensitivity to apoptosis. We furthermore 
suggest that tissue specific responses to dP53 and rpr likely lead to route-of-infection-dependent 
differences in FHV localization, leading to the observed differences in viral resistance and 
tolerance. The mechanisms controlling virus-induced mortality and virus accumulation may be 
controlled independently from each other through different pathways, and remain to be determined. 
Future research may be directed at understanding apoptosis-mediated control of virus replication 
and accumulation, as well as the impact of virus infection on mortality.  
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Tables 
Table 1. Primers used in RT-qPCR analysis. 
 
Primer 
name Nucleotide sequence (5’→3’) Purpose Reference 
Reaper-F ACGGGGAAAACCAATAGTCC qPCR (12) 
Reaper-R TGGCTCTGTGTCCTTGACTG qPCR (12) 
FHV-F CCAGATCACCCGAACTGAAT qPCR (12) 
FHV-R AGGCTGTCAAGCGGATAGAA qPCR (12) 
rpL32-F GACGCTTCAAGGGACAGTATCTG qPCR (26) 
rpL32-R AAACGCGGTTCTGCATGAG qPCR (26) 
 
 
Table 2. Cox-hazard ratio (log-rank) of different mutant Drosophila strains orally infected 
with Flock House virus (FHV) as compared to orally challenged WT flies. 
 
Drosophila 
strain 
Infection 
route 
Hazard 
ratio 
95 % 
C.I. 
p value 
 
P53 -/- 
 
Injection 
 
2.355 
 
8.408 to 
25.42 
 
< 0.0001**** 
 
rpr-UP 
 
Injection 
 
0.2460 
 
0.01316 
to 
0.06018 
 
< 0.0001**** 
 
Dronc-UP 
 
Injection 
 
0.2588 
 
0.01376 
to 
0.06120 
 
< 0.0001**** 
 
P53 -/- 
 
Oral 
 
2.549 
 
2.132 to 
33.54 
 
0.0309* 
 
rpr-UP 
 
Oral 
 
1.183 
 
0.3910 
to 3.413 
 
0.686 
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Chapter 5: General Discussion 
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In nature viral transmissions occur through a variety of routes including aerosol, insects or other 
animals, sexual contact, direct physical contact and ingestion. Viruses have evolved specialized 
mechanisms of evading the host immune system, and often target specific tissues, leading to tissue-
specific localization within the host. Tissue sensitivity to virus infection is usually not ubiquitous, 
therefore the route of viral entry can determine the outcome of infection. Distinct routes of infection 
can lead to different epidemiological effects, as demonstrated for Deformed Wing virus (DWV), a 
dicistrovirus that infects honeybees. Oral DWV transmission leads to asymptomatic infection, 
whereas DWV infection following horizontal transmission by the parasitic mite Varroa leads to 
high mortality (1, 2). This is an example in insects where the route of virus infection has a large 
impact on the severity of infection. Despite the importance of the route of virus infection on viral 
competence and outcome of infection, this topic is often overlooked. 
 
In this thesis host-virus interaction is addressed in the model system Drosophila and focuses 
on the oral route of virus invasion on intrinsic and extrinsic protective mechanisms. Host-pathogen 
interactions in Drosophila often utilize Drosophila C virus (DCV) as a model, as it is a natural 
Drosophila pathogen and can be extremely pathogenic. DCV infection in natural populations is 
though to occur through feeding on contaminated media (3), however the exact route of natural 
infection is yet to be verified experimentally. Laboratory DCV studies have mainly utilized 
injection as a way of delivering virus to flies, as injecting 5000 infectious units (IU) of DCV into 
Drosophila melanogaster leads to 100% mortality 4 - 6 days post-injection (4). In contrast, 
allowing D. melanogaster flies to feed on 1011 IU/ml of DCV for 24 h leads to only ~30% mortality 
by 10 days post-ingestion (Chapter 3) (5). While it is hard to determine how much virus becomes 
internalized following the oral route of infection, a study performed in Drosophila melanogaster 
found that in a 24 h period flies ingested between 0.5 – 2.5 µl of sucrose + yeast media depending 
on the sucrose concentration (6). Even if we assume that the flies are ingesting 0.5 µl of media, that 
would imply that the flies are ingesting approximately 5 x 107 IU/fly of DCV, an amount which is 
far greater than through systemic infection. The difference in susceptibility of flies through feeding 
and injection may be explained by the fact that natural protection mechanisms exist that are 
bypassed through injection. This effect is not unique to Drosophila, as silkworm larvae, for 
example, require a 1000 to 10,000-fold higher viral titers following oral infection with the 
cytoplasmic polyhedrosis virus to achieve the same rate of mortality as systemically infected larvae 
(7). 
 
Following viral ingestion, the virus has to pass through the midgut barrier, which is known 
to be a strong insect barrier for virus infection (8). In baculoviruses, viral fibroblast growth factors, 
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matrix metalloproteases and caspases have been shown to be involved in viral dissemination from 
the lepidopteran midgut (reviewed in 9) however it is yet to be explored whether similar processes 
are involved in viral dissemination in Drosophila. Currently, oral viral infections in Drosophila 
have been largely uncharacterized due to the previous difficulty in developing methods for orally 
infecting flies. Only recently have methods of orally infecting flies been described, which led to the 
discovery of the importance of the nutrient responsive ERK pathway in protection against virus 
infection. The ERK pathway is induced following oral infection with Sindbis virus, vesicular 
stomatitis virus and DCV. Inhibiting the ERK pathway through the knock-down of Erk leads to 
increased midgut infection compared to control flies, suggesting the importance of this pathway in 
protection against virus invasion (10). Other immune pathways are likely to be involved in 
protection against virus invasion of the gut, however a targeted approach will be required to alter 
expression of key immune genes specifically in the gut to determine which other pathways are 
likely to be important. 
 
At the time this thesis was initiated, no reliable way of orally infecting flies existed. 
Recently, in addition to the methods described in Chapter 2 and 3 of this thesis two different 
methods of orally infecting Drosophila have been described in the literature (5, 10). Experiments 
performed in the 1980’s used homogenates of flies fed on DCV-contaminated media to inject into 
DCV-free flies, to show that oral DCV infections lead to persistently infected Drosophila 
populations (3, 11). While these experiments showed that DCV was associated with the flies, the 
method used is not able to discern between viral infection and viral contamination (inactive virus). 
Because exposure to contaminated food does not necessarily lead to viral infection, inactive virus 
associated with the host could be detected using methods that do not analyze an increase in virus 
titer or new virus replication. To determine whether a persistent DCV infection can be achieved 
under laboratory conditions, a new method of detecting active viral replication was required. To this 
end, a single-stranded qPCR (ssqPCR) assay was developed, able to detect only actively replicating 
DCV by targeting the anti-genomic RNA strand (Chapter 2). The assay showed that oral DCV 
infection did not lead to persistently infected populations, contrary to what was previously 
described (3, 11).  
 
While Drosophila has been used extensively as a model organism for host-pathogen 
interaction studies, the research community has largely ignored virus transmission studies, as 
systemic viral infections often lead to early mortality before virus transmission can occur. 
Establishing persistent DCV infections, like those found in natural Drosophila populations (12), 
seems to be hard to achieve in the lab, as orally infecting first instar larvae (Chapter 2) or adults 
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(data not shown) does not lead to a persistently infected population. This suggests that persistent 
DCV infections in nature either occur by a different route of infection or that there are other 
parameters that we do not yet understand which influence the establishment of a persistent DCV 
infection in Drosophila. The ability of FHV to induce persistent infection in Drosophila has not yet 
been determined, and although FHV is not a natural Drosophila pathogen, it can establish a 
persistent infection in Drosophila line 1 cell culture (13) suggesting that persistent FHV infections 
could be possible in adult flies. Establishment of persistently infected fly lines would allow us to 
study natural viral transmission and could allow dissection of molecular mechanisms underpinning 
viral infection and dissemination.  
 
The use of the oral route of virus infection in Drosophila is gaining more attention, in fact a 
recent paper by Ferreira and colleagues studied the regulation of the Toll immune pathway 
following oral infection with DCV and Flock House virus (FHV). Using a standard qPCR to detect 
the abundance of DCV genomes, they suggested that DCV is present in all flies and leads to an 
approximately 30% mortality (5). The infection status of flies was furthermore analyzed using 
immunofluorescence, and the results showed that DCV was present in approximately 25% of flies 
at 5 days post-contamination (5), raising the question of whether the remaining 70% of flies were 
infected. The study furthermore reported a dichotomy in relative DCV genomic copies, where DCV 
was either present at very low abundance, or at 1000 – 10,000-fold higher abundance (5). The 
percentage of flies showing high DCV abundance correlated with the percentage of flies 
succumbing to the infection. Two interpretations are consistent with this observation: 1) the flies 
with low DCV genome abundance are infected but able to control viral replication, or 2) the virus 
genomes detected through standard qPCR come from virus particles which are associated with the 
flies without cell infection. The immunofluorescence data is important because detection of DCV in 
the crop, midgut, hindgut, fat body, testis and trachea (5) indicates successful DCV infection, 
however that was only observed in 25% of all flies. Using immunofluorescence in conjunction with 
ssqPCR could be useful to determine whether the remaining 70% of flies are infected, as inactive 
virus associated with the flies would not be detected using this assay. I believe that the newly 
designed ssqPCR assay could be especially useful for studying oral DCV infections during the early 
stages of infection when DCV is found in low abundance in both infected and uninfected flies. 
Using the standard qPCR assay the infected and un-infected flies would be undistinguishable from 
each other, a problem that could be circumvented using ssqPCR.  
 
While the ssqPCR is a useful method of detecting viral replication, there are some 
limitations to this approach. While the ssqPCR can detect active infection, a lack of DCV detection 
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using this assay does not necessarily indicate that an active infection did not occur at some time-
point before the assay was performed. This could be overcome by time-course ssqPCR studies, 
where a DCV replication could be detected even if it is short term. Furthermore, this assay could be 
used in conjunction with a standard qPCR assay to look for an increase in virus over time. If no 
negative strand was detected using ssqPCR, and the standard qPCR did not detect an increase in 
virus over time, it would be unlikely that the fly was infected.  
 
Establishing oral infection in Drosophila was instrumental to begin dissecting host-virus 
interaction through a natural route of infection. Using the oral route of infection two known 
antiviral protection mechanisms (Wolbachia and apoptosis) were assessed to determine whether 
route-of-infection specific differences in protection mechanisms exist. The first protection 
mechanism that was assessed is the Wolbachia-mediated protection in Drosophila. All experimental 
evidence supporting the role of Wolbachia in antiviral protection is based on intra-thoracic 
injections, while Wolbachia protection following the oral route of virus infection remained 
uncharacterized. From studies performed in mosquitoes, it was clear that Wolbachia can confer 
protection following the oral route of infection in mosquitoes, however it remained to be 
determined whether a similar effect could be observed in Drosophila. Using oral infection methods 
described in Chapter 2, Drosophila larvae and adults were orally infected with DCV to determine 
whether Wolbachia can protect against oral challenge with DCV. The results showed that 
Wolbachia protection is not dependent on the route of infection, as protection against mortality was 
observed following both oral and systemic infections (Chapter 3). Interestingly, Wolbachia 
protection was dependent on the developmental stage, indicating that protection at adult stages is 
not always indicative of protection at larval stages. Because as much as a fifth of all arthropod 
species might benefit from Wolbachia-mediated protection (14), life-stage susceptibility could have 
a large impact on viral circulation in nature, and it is therefore an interesting and important topic 
that could be addressed in future studies.  
 
The second antiviral protection mechanism studied in this thesis focused on the role of 
apoptosis in antiviral protection. Apoptosis is only recently gaining wider acceptance as an antiviral 
immune mechanism in Drosophila and other organisms, therefore relatively little is known about 
how regulation of apoptosis affects viral competence. Using both systemic and oral infections I 
showed that induction/inhibition of apoptosis in Drosophila can have different effects on viral 
resistance and tolerance depending on the route of infection (Chapter 4). This has important 
implications, as this is only the second immune pathway in Drosophila that has been shown to have 
a route of infection-specific effect. Differences in resistance and tolerance observed between 
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systemically and orally infected flies are likely due to differences in FHV localization between the 
two routes of infection, however no studies exist comparing FHV localization in systemically and 
orally infected flies. While the study in chapter 4 of this thesis suggests that differences in 
apoptosis-mediated protection exist depending on the route of infection, certain limitations exist in 
the study. Because any single gene could be involved in multiple pathways, we cannot be sure that 
knocking out dP53 or enhancing reaper expression, which would be expected to inhibit or enhance 
apoptosis respectively, would lead to the observed effects solely due to altered regulation of 
apoptosis. Unfortunately an alternative mutant (Dronc) in which apoptosis was induced did not feed 
on the infection media, therefore we were unable to confirm the results (Appendix 1). It would be 
desirable to perform further studies, where inhibition or enhancement of other genes could be used 
to further understand the importance of apoptosis on antiviral protection. Regardless of the 
limitation, it is clear that differences between the two routes of infection exist, as systemic FHV 
infections in flies in which apoptosis was altered were consistent with the role of apoptosis in 
limiting viral replication, while following oral infection the results were consistent but not 
compelling. Because of the central role of apoptosis in several processes such as homeostasis and 
development, altering apoptosis can lead to mortality of the individuals, impeding further studies. 
One way of overcoming this limitation is by using infectious clones, where pro or anti-apoptotic 
genes are inserted into the virus before challenging the flies. Infecting mosquitoes with viruses 
expressing pro-apoptotic genes leads to induction of apoptosis specifically in cells infected with the 
virus (15), providing a targeted approach of studying the importance of apoptosis in antiviral 
protection.  
 
Regulatory processes in Drosophila might involve both induction and inhibition of 
apoptosis in a tissue and stage of infection-dependent manner. For example, induction of apoptosis 
during the early stages of virus infection can in some circumstances slow down viral replication 
(16), while in other cases induction of apoptosis at the later stages of infection can facilitate viral 
release and dissemination (17-19). Understanding the regulation of apoptosis following the oral 
route of FHV infection will likely require additional approaches. Time-course analysis of the 
regulation of apoptosis following FHV infection could be performed using transferase (TdT)-
mediated dUTP nick end labeling (TUNEL) assay on whole flies. TUNEL analysis is used to detect 
apoptosis, and would provide useful information on the spatial and temporal regulation of apoptosis 
following the oral route of infection. Time course analysis could allow us to determine whether 
apoptosis is occurring in the midgut following oral challenge, and would allow us to study tissue-
specific regulation of apoptosis throughout the infection. Identifying spatial and temporal regulation 
of apoptosis could allow us to alter gene expression in specific tissues at specified times during 
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infection, which would allow us to gain a better understanding of the importance of apoptosis in 
regulating viral infection. 
  
Based on the current literature and the results presented in this thesis, it is becoming 
increasingly clear that the route of infection can have a large effect on the outcome of virus 
infection in Drosophila. Given the current evidence, I consider that immune response in Drosophila 
should be reassessed using the oral route of virus infection. It is possible that the RNAi, JAK-
STAT, Imd and autophagy pathways that been reported to be involved in antiviral protection 
following systemic infection, are more or less important in virus control following oral infection. 
Especially interesting is immune regulation in the midgut, as the midgut represents one of the first 
lines of defense against pathogen invasion. Dissecting the protection mechanisms present within the 
midgut will be essential in understanding virus invasion. 
 
Information gained from studying Drosophila immune regulation will not only be useful in 
understanding host-pathogen interactions in Drosophila, as it could facilitate our understanding of 
regulation of immunity in other insect systems. Studies on antiviral protection mechanisms in 
Drosophila are only recently beginning to gain greater attention, and a lot of questions remain to be 
answered. Gaining a better understanding of Drosophila-virus interactions will require elucidation 
of the pathways involved in primary virus infection and the subsequent host-virus interactions 
leading to viral dissemination and transmission. The information provided in this thesis will 
hopefully encourage other groups focusing on host-virus interactions to use the natural route of 
virus infection.  
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Introduction 
This addendum complements the data from chapter 4 of this thesis. Herein are described the 
additional experiments designed to expand on the results from chapter 4. The aim was to determine 
whether up-regulation of Dronc would lead to similar effects on FHV abundance and tolerance 
compared to rpr up-regulation. Furthermore because the difference between systemic and oral 
infection is in the route of pathogen entry, and because pathogens acquired through oral infection 
have to pass the midgut barrier to establish a prolific infection, I wanted to determine whether 
induction of apoptosis in the gut can affect FHV abundance and fly survival, however some 
unexpected results that are unrelated to virus infection prevented me from collecting usable data.  
 
Methods 
The methods used in this addendum are described in chapter 4 of this thesis. The fly lines used in 
these experiments have been described in chapter 4, except for the driver line used to express rpr in 
the midgut of adult flies. The heat-inducible Myo1A-Gal4, tub-Gal80 driver line was used to drive 
expression of the rpr gene in the midgut epithelial cells (1) and was provided by Dr. Nic Tapon 
from the Francis Crick institute (UK).  
 
Results 
Due to the apparent differences and similarities in apoptosis-related protection between systemic 
and oral infection, I wanted to study the effect of increasing Dronc expression on FHV protection. 
Oral feeding of Dronc-UP flies was performed several times without success. Repeated experiments 
continually lead to approximately 70 – 80 % mortality within 24 h post-feeding regardless of 
whether the flies were fed on mock or FHV contaminated media. Because presence of live yeast in 
the feeding media could be leading to early mortality, live yeast was replaced with heat-inactivated 
yeast. Switching between live and heat-inactivated yeast had no effect on mortality, as similar rates 
of mortality were observed regardless of whether live or heat-inactivated yeast was used (data not 
shown). Following several attempts, a blue food dye was added to the feeding media to observe 
whether flies were ingesting the food. The results showed that WT flies were ingesting both mock 
and FHV- contaminated media, evident by the presence of the blue dye in the abdomen (Figure 1, 
left). In contrast, no blue dye was visible in Dronc-UP flies in contact with either mock or FHV-
contaminated media, suggesting that Dronc-UP flies were not ingesting the media (Figure 1, right). 
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To determine whether lack of feeding was associated with the composition of the media, the flies 
were transferred to standard cornmeal media. Rearing Dronc-UP flies on standard cornmeal media 
did not lead to mortality, suggesting that the composition of the media led to food avoidance.  
 
Due to the inability of orally infecting flies using yeast + PBS media, an alternative method 
of oral infection was tested. Standard cornmeal media was surface contaminated by spreading a 
high concentration of purified FHV (1012 IU/ml) onto the rearing media. Following contamination, 
adult WT and Dronc-UP flies were allowed to feed on virus-contaminated media for 24 or 72 h 
before being transferred onto standard virus-free media. The flies appeared to be feeding on the 
cornmeal media evident by a lack of mortality, however the flies did not appear to become infected, 
as no mortality was observed throughout the course of the experiment (by 20 days post-feeding, 
data not shown). Due to the difficulty associated with orally infecting Dronc-UP flies, this fly line 
was not used in further experiments.  
 
 
 
Figure 1. Representative example of WT (left) and Dronc-UP flies (right) following feeding for 
4 h on yeast extract containing a blue food die. Presence of the dye in WT flies suggests that the 
flies were ingesting the media, while lack of blue dye in the abdomen of Dronc-UP flies suggests 
lack of feeding.  
 
Midgut rpr induction 
Due to the chemical and physical barriers present within the midgut, and because pathogens have to 
breach the midgut barrier to establish a prolific infection within the organism, I wanted to test 
whether inducing rpr expression specifically in the midgut would have an effect on FHV 
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infectivity. An inducible Gal4 driver line was used under a MyoIA promoter that allows expression 
specifically in the enterocyte cells (intestinal absorptive cells) present within the midgut. Induction 
of rpr in the midgut (midgut-rpr-UP) repeatedly lead to approximately 80 – 90 % mortality within 
24 h post-feeding regardless of whether the flies were fed on mock or FHV infected media. No 
further modifications were attempted for this fly line, therefore it is unclear whether the flies were 
dying due to starvation, or whether morbidity was due to extensive tissue damage present within the 
midgut. Due to high mortality and inability to perform oral infection experiments, this fly line was 
excluded from further experiments. 
 
Discussion 
Feeding Dronc-UP flies on yeast + PBS media lead to an abnormally high mortality within 24 h 
post-feeding. A wide range of sensitivity to starvation exist between different Drosophila species, 
leading to a median survival time between 25 h (in D. sechellia) and 171 h (in D. buzzatii) at 25°C, 
however the survival time is substantially lower when water is not present as flies become prone to 
desiccation (2). Because the feeding media is the only source of water present to the flies, mortality 
observed in Dronc-UP and midgut-rpr-UP flies is most likely associated with a lack of fluid intake 
rather than starvation. Feeding on the standard cornmeal media but not on the yeast + PBS media 
suggests that a preference for a food type exists. The same food type preference is not observed in 
WT flies, suggesting that it is likely due to the mutations present in the Dronc-UP and midgut-rpr-
UP flies. The result was somewhat unexpected, as induction of apoptosis has not been previously 
implicated with food preference. 
 
The reason behind avoidance of yeast + PBS feeding media is unclear, however the genes 
involved in apoptosis are often involved in other processes such as fly development and 
homeostasis, ribosome biogenesis, DNA repair and homologous recombination (3-11). Altering the 
expression of genes involved in the apoptotic pathway likely leads to a range of physiological and 
behavioural effects, some of which may involve food preference or increased sensitivity to diet-
related stress. Designing novel methods of orally infecting flies could overcome this problem, 
however this has proven to be especially difficult in the past.  
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The midgut infection barrier  
During early stages of oral infection, the virus needs to cross the midgut barrier to establish a 
systemic infection and spread to the internal tissues. Because the midgut represents both a physical 
and chemical/immune barrier to pathogen infection (12, 13), it is thought that the interaction 
between the pathogen and the host in the midgut can determine whether the insect will become 
systemically infected with the virus. In baculoviruses, viral fibroblast growth factors, matrix 
metalloproteases and caspases have been involved in viral dissemination from the lepidopteran 
midgut (reviewed in 13) however it is currently unclear whether similar processes are involved in 
viral dissemination in Drosophila. 
 
Apoptosis in the gut has been implicated as an important mechanism in protecting 
mosquitoes against arboviral infection. In the refractory mosquito Culex pipiens, infection with 
West Nile virus leads to extensive apoptosis in the midgut, a process which was proposed to limit 
viral replication in the midgut (14). A recent study showed that infecting Aedes aegypti mosquitoes 
with a Sindbis virus infectious clone expressing the Drosophila reaper gene leads to a delay in 
midgut infection and virus replication (15). A strong selection against rpr expression was observed 
in mosquitoes infected with this virus, which lead to the suggestion that arboviruses have evolved 
mechanisms to avoid stimulating apoptosis in mosquitoes (15). Contrary to this finding, RNAi 
silencing of the initiator caspase AeDronc in Aedes aegypti, which would expect to inhibit 
apoptosis, lead to reduced Sindbis virus infection in the midgut, suggesting that some level of 
apoptosis or caspase activity is required for successful viral replication, which is consistent with the 
requirement for caspases demonstrated in the baculovirus system (16). Given the data, it is still 
unclear whether induction and/or inhibition of apoptosis in the gut can serve as a protection 
mechanism against pathogen infection in insects. 
 
Understanding the role of apoptosis in mediating antiviral protection in the midgut would be 
facilitated by immune-fluorescence time-course studies focused at understanding progression of 
FHV infection following the oral route of infection. Construction of FHV infectious clones 
expressing both pro-apoptotic and anti-apoptotic genes would allow regulation of apoptosis to be 
confined to the infected cells, which would provide some evidence about the importance of 
apoptosis following primary FHV infection. Further research is required to better understand the 
mechanisms involved in the establishment of the midgut protection barrier. 
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